PRELIMINARY PROGRAM by TRACKS

Transcription

1 PRELIMINARY PROGRAM by TRACKS Page 1

2 TRACK 0 SELF MEDICATION Room 6 SELF MEDICATION HYPOTHESIS 09:30 19:00 General Director: Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry Hospital Universitari Vall d Hebron, Barcelona, Prof. John Strang. Professor of Psychiatry of Addictions. Director of the National Addiction Centre. London, UK. Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Prof. Nady el Guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Coordinator of the Addictive Disorders Unit, Psychiatry Department, Hospital Italiano de Buenos Aires & University of Buenos Aires, Argentina Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. Dr. Gabriele Fischer Dr. Leo Sher. Associate Clinical Professor of Psychiatry. Medical Center Columbia University. New York, USA. Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. Prof. Alan Green Room 5 11:00 12:30 SYMPOSIUM S3 36 SELF MEDICATION Room 5 12:30 14:00 SYMPOSIUM S3 43 SELF MEDICATION TRACK 1 PSYCHOSIS Room 9 12:30 14:30 SYMPOSIUM S3 44 WHY DO PSYCHOTICS CONSUME CANNABIS IF CANNABIS CAUSES PSYCHOSIS? Prof. Gabriel Rubio. Professor of Psychiatry. Universidad Complutense. Hospital Doce de Octubre. Madrid, Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry. Hospital Universitari Vall d Hebron, Barcelona, Dr. Carlos Pino. Psychiatrist. Drug Addiction Unit of Pontevedra. Page 2

3 Dr. José María Vázquez. Psychiatrist. CAS Sants (ASPB ABD). Vocal for Catalonia of the SEPD. Barcelona. Room 9 14:30 16:00 BEST POSTER IN DUAL DIAGNOSIS IN PSYCHOSIS CONTEST CCC3 03 President: Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry. Hospital Universitari Vall d Hebron, Barcelona, Vicepresident: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Coordinator: Dr. Begoña Gonzalvo. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, TRACK 2 DEPRESSION Room 1 09:30 11:00 SYMPOSIUM S2 55 DEPRESSION AND ADDICTIVE DISORDERS Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar, Universitat Autònoma Barcelona, ANIMAL MODELS IN DEPRESSION AND ADDICTIVE DISORDERS Prof. Olga Valverde. Universitat Pompeu Fabra, Barcelona, PHARMACOLOGICAL TREATMENT OF COMORBID DEPRESSION AND ADDICTIVE DISORDERS Prof. Magi Farré. IMIM Institut de Recerca Hospital del Mar, Universitat Autònoma Barcelona, Room 5 16:30 18:30 SATELLITE SYMPOSIUM SS2 08 AGOMELATINE, NEW EXPECTATIONS FOR PATIENTS WITH DEPRESSION Sponsored by Servier Rovi Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, AGOMELATINE: DIFFERENTIAL CLINICAL BENEFITS IN DEPRESSION Prof. Gabriel Rubio. Professor of Psychiatry. Universidad Complutense. Hospital Doce de Octubre. Madrid, USE OF AGOMELATINE AND DUAL DEPRESSION Dr. José Martínez Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Page 3

4 TRACK 3 BIPOLAR DISORDERS Wednesday 5th Room 1 16:00 17:30 SYMPOSIUM S1 01 TEMPERAMENTS, BIPOLAR SPECTRUM AND SUBSTANCE ABUSE. CLINICAL AND THERAPEUTICAL ASPECTS Chair/Presenter: Prof. Icro Maremmani, University of Pisa. Italy TOWARDS A UNITARY PERSPECTIVE ON THE BIPOLAR SPECTRUM AND SUBSTANCE ABUSE: OPIATE ADDICTION AS A PARADIGM Prof. Icro Maremmani, University of Pisa, Italy THE EFFECTS OF PSYCHIATRIC SEVERITY ON THE OUTCOME OF OPIOID AGONIST MAINTENANCE TREATMENT Dr. Pier Paolo Pani, ASL8, Cagliari, Italy COCAINE ABUSE IN ALCOHOLICS: EVIDENCE FOR A BIPOLAR CONNECTION Dr. Matteo Pacini, G. de Lisio Institute of Behavioural Sciences, Pisa, Italy DUAL DIAGNOSIS AND CHRONOLOGY OF ILLNESS HEROIN DEPENDENT PATIENTS Dr. Angelo Giovanni Icro Maremmani, University of Pisa, Italy Room 3 11:30 13:30 SATELLITE SYMPOSIUM SS2 01 ASENAPINE IN DUAL BIPOLAR PATIENTS Sponsored by Lundbeck Prof. Julio Vallejo. Professor of Psychiatry. University of Barcelona, Room 3 13:30 15:30 SYMPOSIUM S2 25 DUAL BIPOLARITY: CLINICAL AND THERAPEUTICAL PROGRESS Sponsored by Servier Rovi Prof. Jerónimo Saiz. Professor of Psychiatry. University of Alcalá de Henares. Madrid, DUAL DIAGNOSIS IN FIRST EPISODES OF THE BIPOLAR DISORDER Prof. Ana González Pinto. Head of Section. Psychiatry Service. Hospital Santiago Apóstol. Vitoria, ADDICTIONS AND BIPOLAR DISORDER: NEUROCOGNITIVE AN THERAPEUTIC ASPECTS Prof. Eduard Vieta. Psychiatry Service. Hospital Clinic of Barcelona. Universitat de Barcelona, INTEGRATED GROUP THERAPY FOR BIPOLAR DISORDER AND SUBSTANCE ABUSE: AN EMPIRICALLY VALIDATED TREATMENT Prof. Roger Weiss. Professor of Psychiatry, Harvard Medical School. Boston, USA. Page 4

5 Room 3 15:30 17:00 SYMPOSIUM S2 28 BIPOLAR DISORDER AND COMORBIDITY VIEWED BY PSYCHOPHARMACOLOGY, NEUROIMAGING, NEUROPSYCHOLOGY AND PSYCHOTHERAPY Chair/Presenter: Dr. Josep Solé Puig, Complejo de Salud Mental Benito Menni, Sant Boi de Llobregat. Barcelona, LATEST DEVELOPMENTS IN THE PSYCHOPHARMACOLOGY OF ADDICTIONS COMORBID BIPOLAR DISORDER Dr. Benedikt Amann, Benito Menni CASM, CIBERSAM, Germany. NEUROIMAGING IN BIPOLAR DISORDER WITH AND WITHOUT DUAL DIAGNOSIS: CURRENT DATA Dr. Paloma Fernández Corcuera, Benito Menni CASM, Sant Boi, NEUROPSYCHOLOGY AND BIPOLAR DISORDER WITH AND WITHOUT DUAL DIAGNOSIS: STATE OF THE ART Dr. Laura Blanco Presas, Benito Menni CASM, Sant Boi, COMORBID BIPOLAR DISORDER: INTEGRATED OR HYBRID PSYCHOTHERAPY? Dr. Josep Solé Puig, Benito Menni CASM, Sant Boi, Room 3 17:00 19:00 SATELLITE SYMPOSIUM SS2 03 TWO SIDES OF DUAL DIAGNOSIS IN BIPOLAR DISORDER: PRESENT AND FUTURE Sponsored by Bristol Myers Squibb Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar, Universitat Autònoma Barcelona, DUAL DISORDER: NEW CHALLENGES IN PATIENTS WITH BIPOLAR DISORDER Prof. Ana González Pinto. Head of Section. Psychiatry Service. Hospital Santiago Apóstol. Vitoria, CLINICAL MANAGEMENT OF DUALLY DIAGNOSED PATIENTS IN CLINICAL PRACTICE Dr. José María Vázquez. Psychiatrist. CAS Sants (ASPB ABD). Vocal for Catalonia of the SEPD. Barcelona. QUALITY OF LIFE IN DUAL PATIENTS: MEDICAL AND PSYCHIATRIC COMORBIDITIES Dr. Francina Fonseca. Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar, Universitat Autònoma de Barcelona, TRACK 4 ANXIETY DISORDERS Room 9 09:00 10:30 MEETING WITH THE EXPERT DUAL DIAGNOSIS AND GAD: INSOMNIA AS A CONSTANT Sponsored by Pfizer Page 5

6 Dr. Fermín Ordoño. Neurophysiology Service Hospital Arnau de Vilanova. Valencia, Dr. César Pereiro. Inpatient Psychiatric Unit. Complexo Hospitalario Arquitecto Marcide Profesor Novoa Santos. Ferrol, Room 9 11:00 12:30 SYMPOSIUM SS2 04 THE APPROACH TO GENERALIZED ANXIETY AND ITS COMORBIDITIES IN DAILY CLINCAL PRACTICE: CLINICAL WORKSHOPS Sponsored by Pfizer Dr. Antonio Terán. Coordinator of the Centro Ambulatorio de Atención a Drogodependientes San Juan de Dios. Palencia, Dr. Anna Lligoña. Alcohology and Addictions Unit. Hospital Clínico. Barcelona, Dr. Josep Guardia. Unit of Addictive Behaviors. Psychiatry Service. Hospital de la Santa Creu i Sant Pau. Barcelona, TRACK 5 PERSONALITY DISORDERS Room 6 17:00 19:00 SYMPOSIUM S2 13 FROM PERSONALITY TO ADDICTION THROUGH NEUROBIOLOGY Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. INTRODUCTION Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. DO WE STILL SUPPORT THE MAIN ROLE OF IMPULSIVITY IN ADDICTION? Prof. Rafael Maldonado, Universidad Pompeu y Fabra, Barcelona. CANNABIS, CLUSTER A AND SCHIZOPHRENIA: SOME LIGHT ON THE CONTROVERSY? Dr. Fernando Cañas. Chief of Psychiatry. Hospital Rodriguez Lafora, Madrid, BORDERLINE PERSONALITY DISORDER AND OPIOIDS: A PARADIGM OF THE PERSONALITY ADDICTION INTERRELATION Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Room 2 09:30 11:00 WORKSHOP W4 14 THE TREATMENT OF PATIENTS WITH A (SEVERE) PERSONALITY DISORDER AND SUBSTANCE USE DISORDER Chairs/Presenters: Dr. Albert Dijkhuizen. Psychiatrist, GGz Eindhoven en de Kempen, Eindhoven, The Netherlands. Mrs. Anneke van Wamel. Research Associate, Programme Reintegration, Trimbos Page 6

7 Institute, Utrecht, The Netherlands. Room 2 11:00 12:30 SYMPOSIUM S4 67 DUAL EFFECT OF PATHOLOGY AND SUBSTANCE ABUSE IN THE PATHOPYSHIOLOGY AND PROGNOSIS OF BORDERLINE PERSONALITY DISORDER Dr. Víctor Pérez Sola. Psychiatry Unit Director of H. Santa Creu i Sant Pau, Barcelona, COMMON NEUROBIOLOGICAL BASES BETWEEN BPD AND SUD Prof. José Luis Carrasco Perera. Head of the Unit Personality Disorders at the Hospital Clínico San Carlos, Madrid, NEURODEVELOPMENTAL DISORDERS INTERACTION: BPD, SUD AND ADHD Dr. Marc Ferrer Vinardell. PAI TLP la Caixa Program Coordinator of the Psychiatry Department of the Hospital Universitari Vall d Hebron. Barcelona, BPD RESISTANT. INFLUENCE OF THE TOXIC CONSUMPTION IN THE EVOLUTION AND PROGNOSIS OF PATIENTS WITH BPD Dr. Juan Carlos Pascual Mateos. TLP Program Coordinator of the Psychiatry Department of the Hospital de la Santa Creu i Sant Pau. Barcelona, Room 2 12:30 14:00 SYMPOSIUM S4 72 DRUG, PERSONALITY AND RELATIONSHIP WITH MENTAL HEALTH, CRITERIA FOR YOUNG PEOPLE Prof. Pablo García Medina. Professor of Department of Personality, Evaluation and Psychological Treatment of the ULL. Tenerife. PERSONALITY AND RELATIONSHIP WITH MENTAL HEALTH CRITERIA FOR YOUNG PEOPLE IN THE CANARY ISLANDS Prof. Pablo García Medina. Professor of Department of Personality, Evaluation and Psychological Treatment of the ULL. Tenerife. PERSONALITY & HEALTH: ADOLESCENTS WITH COURT DECISIONS D. Francisco David Lorenzo González. Psychologist Project Team of PROYECTA ME, ACJ SAN MIGUEL. Tenerife. Canary Islands. PSYCHOPATHOLOGICAL PROFILE, SOCIAL COMPETENCE, HOSTILITY AND EMOTIONAL EXPRESSION IN YOUTH IN TREATMENT Dr. A. Rita Martín Caballero. Clinical Psychologist of the Day Centre "Cercado del Marqués" of the ACJ SAN MIGUEL and Teaching Assistant ULL. Tenerife. Canary Islands. TRACK 6 TDAH Room 5 08:30 09:30 BREAKFAST WITH THE EXPERT IN DUAL DIAGNOSIS AND ADHD Dr. José Martínez Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University Page 7

8 CEU Cardenal Herrera, Valencia, Dr. Alfredo Gurrea Escajeda. Psychiatrist. UASA Huesca (Unidad de Atención y Seguimiento de Adicciones). Psychiatry service. Room 1 11:00 13:00 SYMPOSIUM S2 19 NEUROBIOLOGICAL BASIS OF COMORBIDITY BETWEEN ADHD AND SUBSTANCE USE DISORDERS Prof. Wim van den Brink. Academic Medical Center. University of Amsterdam, The Netherlands. THE PREVALENCE OF ADHD IN TREATMENT SEEKING PATIENTS WITH SUBSTANCE USE DISORDERS IN EUROPE, THE USA, AUSTRALIA AND SOUTH AFRICA: PRELIMINARY RESULTS OF THE IASP STUDY Dr. Guert van de Glind. ICASA Foundations. Utrecht, The Netherlands. NEUROIMAGING THE ACTIONS OF METHYLPHENIDATE TREATMENT IN ADHD WITH AND WITHOUT SUBSTANCE USE DISORDERS Dr. Cleo L. Crunelle. Psychiatry Department and Department of Nuclear Medicine. Academic Medical Center, University of Amsterdam, The Netherlands. ADULT ADHD AND SUD: COMMON GENETIC VULNERABILITY Dr. Josep Antoni Ramos Quiroga. ADHD Program Coordinator. Psychiatry Service. Hospital Universitari Vall d'hebron. Barcelona, PREVALENCE OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SUBSTANCE USE DISORDER PATIENTS: A META ANALYSIS AND META REGRESSION ANALYSIS Dr. Katelijne van Emmerik van Oortmerssen. Arkin Mental Health and Addiction Research Department. Amsterdam, The Netherlands. Room 1 13:00 14:30 SYMPOSIUM S2 26 TO BE CONFIRMED Dr. Philip Asherson. Professor of Molecular Psychiatry. Kings College London. UK. Dr. Philip Shaw. Staff Clinician. Child Psychiatry Branch. Intramural Program. NIMH. USA. Dr. Pieter Jan Carpentier. Novadic Kentron. Network for Addiction Treatment Services. Vught, The Netherlands. Dr. Josep Antoni Ramos Quiroga. ADHD Program Coordinator. Psychiatry Service. Hospital Universitari Vall d'hebron. Barcelona, Room 1 14:30 16:00 CLINICAL CASE IN DUAL DIAGNOSIS IN ADHD CONTEST CCC2 01 President: Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry. Hospital Universitari Vall d Hebron, Barcelona, Page 8

9 Vicepresident: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Coordinator: Dr. José Martínez Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Room 4 16:30 18:30 SYMPOSIUM S2 31 ADHD SYMPOMTS IN HIGH RISK ADULT POPULATIONS: COCAINE USERS AND PARENTS OF CHILDREN WITH ADHD Dr. José Ramón Gutiérrez Casares. Hospital Perpetuo Socorro. Complejo Hospitalario Universitario de Badajoz. Dr. José Ramón Gutiérrez Casares, Hospital Perpetuo Socorro, Badajoz, Dra. María Teresa Martín Lunar, Fundación Sorapán de Rieros, Badajoz, Dr. José Miguel Zoido Ramos, CEDEX SES, Badajoz, Room 10 12:30 14:00 WORKSHOP W4 26 DUAL DIAGNOSIS IN DEVELOPMENTAL DISORDER (AUTISM SPECTRUM DISORDERS ADHD) Chairs/Presenters: Dr. Patricia J.M. Van Wijngaarden Cremers MD. Psychiatrist, Head of Department of Addiction and Developmental Disorders, the Dimence GGz Zwolle. The Netherlands. Dr. Rutger Jan Van der Gaag MD PhD. Professor of Psychiatry (Child and Adolescent). University Medical Centre, St. Radboud Nijmegen. Department of Psychiatry and Karakter University Centre for Child and Adolescent Psychiatry. Zwolle, The Netherlands. TRACK 7 IMPULSIVITY Room 4 17:00 18:30 SYMPOSIUM S3 59 IMPULSIVITY AND DUAL DIAGNOSIS Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, STIMULANTS AND IMPULSIVITY Dr. Constanza Daigre. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, IMPULSIVITIY AND DEPRESSANT DRUGS To be confirmed IMPULSIVITY, COGNITION AND ADDICTION Dr. Carlos Jacas. Psychiatry Service. Hospital Universitari Vall d Hebron, Page 9

10 Barcelona, TRACK 8 POST TRAUMATIC STRESS Room 4 11:00 12:30 SYMPOSIUM S3 35 PTSD, SELF MEDICATION AND CONTEXT: FUNCTIONAL RELATIONSHIPS BETWEEN PTSD CLUSTER CHANGES AND ALCOHOL AND STIMULANT OUTCOMES IN THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK WOMEN AND TRAUMA STUDY Dr. Denise Hien, Ph.D., City University of New York and Columbia University College of Physicians and Surgeons. New York, USA. AN OVERVIEW OF THE SELF MEDICATION MODEL IN THE TREATMENT OF PTSD AND SUD Dr. Denise Hien, Ph.D., City University of New York and Columbia University College of Physicians and Surgeons. New York, USA. THE ROLE OF ALCOHOL MISUSE IN PTSD OUTCOMES Dr. Aimee N. C. Campbell, Ph.D., Columbia University College of Physicians and Surgeons, NY, USA. ASSOCIATIONS BETWEEN PTSD SYMPTOMS AND STIMULANT USE Dr. Lesia M. Ruglass, Ph.D., City University of New York, NY, USA CONTEXTUAL FACTORS IN THE TREATMENT OF PTSD AND SUD Dr. Lisa Cohen, Ph.D., New York State Psychiatric Institute at Columbia University Medical Center, NY, USA. CLINICAL AND SUPERVISORY CHALLENGES IN IMPLEMENTING EVIDENCE BASED PRACTICES FOR PTSD AND SUD IN COMMUNITY ADDICTION TREATMENT PROGRAMS Dr. Lisa Litt, Ph.D., Columbia University College of Physicians and Surgeons, NY, USA. Room 4 12:30 14:00 SYMPOSIUM S3 42 UPDATES IN PTSD COMORBIDITY AND ADDICTIONS Chairs: Dr. Sara Gila Kinori Fidel, Psychiatry Department, Hospital Universitari Vall d'hebron. Barcelona, Francisco José Eiroa Orosa, Psychiatry Department, Hospital Universitari Vall d'hebron, Barcelona, PREVALENCE OF EARLY TRAUMA AND PTSD IN SUBSTANCE DEPENDENCE Dr. Martin Driessen. Ev. Hospital Bielefeld. University of Bielefeld. Bethel, Germany. CHILDHOOD TRAUMA, PTSD AND ALCOHOL USE DISORDERS Dr. Willie Langeland. Deptartment of Psychiatry, Vrije Universiteit Medical Center. Amsterdam, The Netherlands. INTEGRATED TREATMENT FOR PTSD AND SUBSTANCE ABUSE Dr. Ingo Schäfer. Deptartment of Psychiatry and Psychotherapy University Page 10

11 Medical Center Hamburg Eppendorf. Center for Interdisciplinary Addiction Research (CIAR), University of Hamburg. Germany. CO MORBID ADHD, DEPRESSION, PTSD, AND SUBSTANCE ABUSE Dr. Causenge Cangin, Declare Therapy Center, Covington, USA. TRACK 9 EATING DISORDERS Wednesday 5th Room 6 16:00 17:30 SYMPOSIUM S1 09 ADVANCES IN EATING DISORDERS AND DUAL DIAGNOSIS: FROM ADDICTIVE MODEL TO CLINICAL PRACTICE Dr. Ignacio Basurte Villamor. Psychiatry Service. Hospital Gregorio Marañón. Madrid. TCA ADDICTIVE MODEL Prof. Luis Rojo. Professor of Psychiatry, University of Valencia. Head of Section of Child and Adolescent Psychiatry and Eating Disorders, University Hospital La Fe. Valencia, IMPULSIVITY, EATING DISORDERS AND DUAL PATHOLOGY Dr. Marina Díaz Marsá. Hospital San Carlos. Associate Professor. Universidad Complutense. Madrid. DAILY CLINICAL PRACTICE OF EATING DISORDERS AND DUAL PATHOLOGY Prof. Francisco Ferre Navarrete. Head of Psychiatry. Eating Disorders Program. Hospital General Universitario Gregorio Marañón. Madrid, Wednesday 5th Room 6 17:30 19:00 SYMPOSIUM S1 05 ADDICTIVE AND FOOD DISORDERS: NEW BIOLOGICAL, CLINICAL AND PHARMACOLOGICAL PERSPECTIVES Prof. Luis Fernando Alguacil Merino. Professor of Pharmacology, Universidad San Pablo CEU, Madrid. AN EVOLUTIONARY PERSPECTIVE ON HUMAN BEHAVIOUR: THE CASE OF EATING BEHAVIOUR Prof. Laureano Castro Nogueira. Professor at UNED, Madrid. ADDICTION MODEL OF EATING DISORDERS Dr. Luis Beato Fernández. Director of the Eating Disorders Unit. General Hospital. Ciudad Real, EXPERIMENTAL MODELS OF ADDICTION AND EATING DISORDERS: BRIDGING THE GAP BETWEEN BASIC AND CLINICAL RESEARCH Prof. Luis Fernando Alguacil Merino. Professor of Pharmacology, Universidad San Pablo CEU, Madrid. NEW TRENDS IN THE PHARMACOLOGICAL TREATMENT OF ADDICTION AND EATING DISORDERS Prof. Cecilio Álamo González. Pharmacology Professor. University of Alcalá. Madrid, Page 11

12 TRACK 10 CHILD AND ADOLESCENT PSYCHIATRY Wednesday 5th Room 1 17:30 19:00 WORKSHOP W1 03 BEFORE THE NEEDLES MULTIDISCIPLINARY DRUG COUNSELLING AND TREATMENT FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS Dr. Camilla Urhammer Weltz. Psychologist. Copenhagen, Denmark. MULTIDISCIPLINARY WORK EFFORTS Dr. Camilla Urhammer Weltz. Psychologist. Copenhagen, Denmark. DIAGNOSING CLIENTS HAVING SUBSTANCE USE DISORDERS, WITH PSYCHIATRIC DISORDERS Dr. Mie Bonde. Consultant of Child and Adolescent Psychiatry and Drug Advisory Counsellor. Copenhagen, Denmark. EXISTENTIAL PSYCHOTHERAPY Dr. Silas Houlberg. Psychologist. Copenhagen, Denmark. Room 12 11:00 12:30 SYMPOSIUM S3 38 UPDATES IN ADOLESCENTS AND DUAL DIAGNOSIS Dr. Lluis San. Hospital Sant Joan de Deu Servei de Psiquiatria i Psicología. Barcelona. SUBSTANCE USE AMONG ADOLESCENT FIRST EPISODE PSYCHOTIC PATIENTS Dr. Marta Pardo. Unitat de Conductes Addictives de l'adolescent. Servei de Psiquiatria i Psicología. Hospital Sant Joan de Deu. Barcelona. DUAL DIAGNOSIS IN ADOLESCENTS: ADHD, CANNABIS AND COCAINE, CHALLENGES IN THE INTERVENTION Dr. Javier Goti Elejalde. Servei de Psiquiatria i Psicología Infantil i Juvenil. Hospital Clínic Barcelona. SUBSTANCE USE DISORDERS IN ADOLESCENTS WITH BORDERLINE PERSONALITY DISORDER Dr. Marc Ferrer Vinardell. Servei de Psiquiatria. Hospital Universitari Vall d'hebron. Barcelona. IMPACT OF ADOLESCENT SUBSTANCE USE IN CHILD AND ADOLESCENT PSYCHIATRIC EMERGENCIES Dr. Josep Matalí Costa. Unitat de Conductes Addictives de l'adolescent. Servei de Psiquiatria i Psicología. Hospital Sant Joan de Deu. Barcelona. Room 12 12:30 14:00 SYMPOSIUM S3 46 CHILD AND ADOLESCENTS AND DUAL DIAGNOSIS Page 12

13 Dr. Celso Arango. Head of Child and Adolescent Psychiatry. Hospital General Universitario Gregorio Marañón. Madrid, (TO BE CONFIRMED) Room 11 09:30 11:00 WORKSHOP W4 18 DUAL JOY: MULTIMODAL INTERVENTION PROGRAM FOR CHILDREN AND ADOLESCENTS IN STATE STREET IN THE CITY OF MEDELLIN, COLOMBIA Dr. Jorge Mario Rubio Sánchez. Drug Psychologist Specialist. DX Service Coordinator Mental Hospital of Antioquia. Colombia. Dr. Hernán Darío Giraldo. Psychiatrist. Specialist in Children and Adolescents. Mental Hospital of Antioquia. Colombia. Elsa Nidia Toro Balcázar. Psychologist specialist in Human Resource Management. Municipality of Medellin. Colombia. Room 11 11:00 12:30 SYMPOSIUM S4 71 EPIGENETICS AND DUAL DIAGNOSIS: ECOSYSTEMIC INFLUENCE IN CHILDREN AND ADOLESCENTS Dr. Emma Saad de Janon. Catholic University of Santiago de Guayaquil. Guayaquil, Ecuador TRANSIENT AND DEFINITIVE LOSSES IN CHILDHOOD AND ADOLESCENCE: GRIEF PROCESSES IN THE GENESIS OF DUAL PATHOLOGY Dr. Emma Saad de Janon. Catholic University of Santiago de Guayaquil. Ecuador. ABANDONMENT AND ABUSE DURING CHILDHOOD: ANOTHER PATHWAY TO DUAL DIAGNOSIS? Dr. Rodrigo Chamorro Oschilewsky. Universidad Central de Chile. Santiago de Chile, Chile. POST TRAUMATIC STRESS DISORDER IN CHILDREN. BEHAVIORAL AND EMOTIONAL CONSEQUENCES AS DIVERSIONS IN THE DEVELOPMENT CYCLE Dr. Roberto Chaskel. Hospital Militar Central. Bogotá, Colombia. Room 11 12:30 14:00 WORKSHOP W4 27 ADOPTED AND NON ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL PATHOLOGY: A COMPARATIVE DIAGNOSTIC STUDY Chairs/Presenters: Dr. Jordi Royo Isach. Clinical Psychologist. Clinical Director of Amalgama 7, Biopsychosocial Care Center. Barcelona, Dr. Ramon Martí Montraveta. Psychiatrist. Medical Director of Amalgama 7, Biopsychosocial Care Center. Barcelona, TRACK 11 TRANSCULTURAL PSYCHIATRY Page 13

14 Room 1 12:30 14:00 SYMPOSIUM S3 39 CURRENT TRENDS OF TRANSCULTURAL RESEARCH ON ADDICTIONS Dr. Francisco Collazos. Coordinador del Programa de Psiquiatría Transcultural. Hospital Univesitari Vall d Hebron. Barcelona, THE EPIDEMIOLOGIC PERSPECTIVE IN THE RESEARCH OF IMMIGRATION AND DRUG USE Dr. María Teresa Brugal. Director of Addictions. Barcelona Public Health Agency. Barcelona, EMIC VISION OF ADDICTIONS Dr. Joan Obiols. Mental Health Services Director. Andorra. AN APPROACH OF ETHNIC MINORITIES FROM THE AMERICAN EXPERIENCE Dr. Iván Montoya. Clinical Director of Pharmacotherapies and Medical Consequences of Drug Abuse. National Institute on Drug Abuse (NIDA). Bethesda, Maryland, USA. TRACK 12 GENDER AND DUAL DIAGNOSIS Room 1 09:30 11:00 SYMPOSIUM S4 64 EMPHASIZING WOMEN IN DUAL DIAGNOSIS. RESEARCH ON GENDER ASPECTS OF DUAL DIAGNOSIS Dr. Mª Cristina Pinet Ogué. Unit of Addictive Behaviors. Psychiatry Service. Hospital Sant Creu i Sant Pau. Barcelona, GENDER DIFFERENCES IN DUAL DIAGNOSIS Dr. Laia Miquel de Montagut. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron. Barcelona, VIOLENCE, GENDER AND DUAL DIAGNOSIS Dr. Gail Gilchrist, University of Greenwich, London, Reino Unido. IMIM Parc de Salut Mar. Barcelona, GENDER AND SUBSTANCE USE IN BIPOLAR DISORDER Dr. Jesús Vicente Cobo Gómez. Psychaitry Service. Hospital Parc Taulí, Sabadell. Barcelona, PREGNANCY RELATED SUBSTANCE USE AND POSTPARTUM DEPRESSION Dr. Mª Llüisa Imaz. Psychiatry Service. Hospital Clínic. Barcelona, Room 1 11:00 12:30 SYMPOSIUM S4 66 YOUNG WOMEN AND DUAL DIAGNOSIS Prof. María Dolores Franco Fernández. Universidad de Sevilla. THE COMPLEX REALTIONSHIP BETWEEN PERSONALITY DISORDERS AND DUAL DIAGNOSIS IN YOUNG WOMEN Prof. María José Moreno Díaz. Professor of Psychiatry. Universidad de Page 14

15 Córdoba. Dr. María José Jaén. Mir3 Psychiatry. Hospital Reina Sofía de Córdoba. EATING DISORDERS AND SUBSTANCE USE/ABUSE Dr. Marina Díaz Marsá. Hospital San Carlos. Associated Professor. Universidad Complutense. Madrid. VIOLENCE AND SUICIDE IN YOUNG WOMEN WITH DUAL DIAGNOSIS Prof. Pilar A. Sáiz Martínez. Professor of Psychiatry. Universidad Oviedo. Room 1 12:30 14:00 WORKSHOP W4 23 DUAL DIAGNOSIS AND TRAUMA SURVIVORS OF CHILDHOOD SEXUAL ABUSE IMPLICATIONS FOR PRACTICE Chairs/Presenters: Mrs. Lois Dugmore. Consultant Nurse Dual Diagnosis. Leicestershire Partnership NHS Trust. Bradgate Unit. Glenfield Hospital. Leicester, United Kingdom. Mrs. Jackie Channell. Consultant Nurse Dual Diagnosis. Leicestershire Partnership NHS Trust. Bradgate Unit. Glenfield Hospital. Leicester, United Kingdom. TRACK 13 IMPAIRED DOCTORS AND DUAL DIAGNOSIS Room 4 10:30 12:30 SYMPOSIUM S2 17 NEW CHALLENGES IN TREATING ADDICTIONS IN HEALTH CARE WORKERS Chairs/Presenters: Prof. Dr. Humberto Guajardo Sáinz. Addictions Unit, Faculty of Medical Sciences, University of Santiago de Chile, Chile. Diana Kushner Lanis. Antropologist. Addictions Unit, Faculty of Medical Sciences, University of Santiago de Chile, Chile. Room 4 12:30 14:30 SYMPOSIUM S2 22 DOCTORS WITH DUAL DIAGNOSIS? PAIME (PROGRAMA DE ATENCIÓN INTEGRAL AL MÉDICO ENFERMO) CASES Dr. Mª Pilar Lusilla. Assistant psychiatrist of the Hospital Universitari Vall d Hebron. Barcelona, PREVALENCE OF DUAL DIAGNOSIS IN THE PHYSICIAN AND ITS IMPLICATIONS IN CLINICAL PRACTICE Dr. Mar Sánchez. Director of the Addictive Behaviors Unit. Psychiaty Service. Hospital Provincial de Ciudad Real. DUAL DIAGNOSIS AND SELF MEDICATION: THE ROLE IN THE SAD TRIAD ALCOHOL DEPRESSION SUICIDE Dr. Mª Pilar Lusilla. Assistant psychiatrist of the Hospital Universitari Vall d Hebron. Barcelona, ASSESSMENT OF DUAL DIAGNOSIS IN THE SICK DOCTOR Dr. Marina Comin. Hospital Universitari Vall d Hebron. Barcelona, Page 15

16 A MODEL OF INTEGRAL AND INTENSIVE CARE IN THE PATIENT PHYSICIAN WITH DUAL DIAGNOSIS Dr. Eugeni Bruguera. Psychiatry Service. Hospital Universitari Vall d Hebron. Barcelona, Room 4 14:30 16:30 WORKSHOP W2 09 STRATEGIES FOR PREVENTING, DIAGNOSING AND TREATING DUAL PATHOLOGY IN HEALTH CARE PROFESSIONALS Chairs/Presenters: Dr. Mª Dolores Braquehais Conesa. Psychiatrist. Jefa Clínica. Unidad Hospitalización. PAIMM Barcelona. Dr. Miquel Jordi Bel Aguado. PAIMM. Barcelona. Psychiatrist. Unidad de Hospitalización y de Consultas Externas. PAIMM Barcelona. TRACK 14 EVALUATION PROCESSES Room 11 17:00 18:30 WORKSHOP W2 10 USING ELECTRONIC MEDICAL RECORD REMOTE DATA ACCESS TO COMPARE INPATIENT BED UTILIZATION IN THE 12 MONTHS PRE AND POST RESIDENTIAL SUBSTANCE ABUSE TREAMTMENT (RRTP) Chair/Presenter: Dr. Kathleen Stack & Dr. Jose Edwin Nieves. Psychiatrists. Veterans Affairs Medical Center, Hampton, VA, USA. Room 2 14:00 15:30 SYMPOSIUM S3 48 EVALUATION PROCESSES IN DUAL DIAGNOSIS Chairs: Prof. Deborah Hasin. Columbia University Department of Psychiatry. New York, USA. Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar, Universitat Autònoma Barcelona. DIAGNOSIS OF PSYCHIATRIC COMORBIDITY IN SUD, WHAT ABOUT DSM V? Prof. Deborah Hasin. Columbia University Department of Psychiatry. New York, USA. SCREENING INSTRUMENTS OF PSYCHIATRIC COMORBIDITY: THE DDSI Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar, Universitat Autònoma Barcelona. EVALUATION OF AN INTEGRATED SYSTEM FOR DUAL DIAGNOSED PATIENTS: MADRID S MODEL Dr. Francisco de Asís Babín Vich. Director del Instituto de Adicciones de Madrid. DUAL DIAGNOSIS IN THE ELDERLY: TREATMENT GOALS AND OUTCOMES Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. Page 16

17 TRACK 15 OPIOID SYSTEM AND DUAL DIAGNOSIS Room 4 08:30 09:30 BREAKFAST WITH THE EXPERT IN DUAL DIAGNOSIS AND OPIOIDS Dr. Ricardo Ortega García. Psychiatrist. Head of Section, Drug Addiction Unit. Hospital Nuestra Señora del Rosell. Murcia, Sponsored by Reckitt Benckiser Pharmaceuticals Room 2 09:30 11:30 SYMPOSIUM S2 14 OPIOIDS, ALCOHOL AND PSYCHIATRIC COMORBIDITY Dr. Luís Patrício. Psychiatrist. Clinic Chief. Centro das Taipas IDT, Lisbon, Portugal. POORLY HEALED HEROIN ADDICT, ALCOHOLIC ENSURED? Dr. Juan Francisco Ramírez López. Psychiatrist. Provincial Drug Dependence and Addiction Services, Huelva, UNKNOWN PSYCHIATRIC DISORDERS AND POLYDRUG USE Dr. Didier Touzeau. Psychiatrist. Clinique Liberté Bagneux, Paris, France. AFFECTIVE DISORDERS IN ADDICTS IN SUBOXONE TREATMENT Dr. Edna Leite. Psychiatrist. Hospital da Horta, Horta, Faial, Açores, Portugal. MAINTENANCE OPIOID, ALCOHOL CONSUMPTION AND PSYCHIATRIC COMORBIDITY TREATMENT Dr. Antonio Costa. Psychiatrist. IDT, IP, Lisbon, Portugal. Room 2 11:30 13:30 SYMPOSIUM S2 20 BUPRENORPHINE/NALOXONE: AN OPIOID WITH USEFUL PSYCHOTROPIC PROPERTIES IN DUALLY DIAGNOSED OPIATE DEPENDENT PATIENTS Sponsored by Reckitt Benckiser Pharmaceuticals Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry. Hospital Universitari Vall d Hebron, Barcelona, PSYCHIATRIC COMORBIDITIES AND THERAPEUTIC MANAGEMENT IN OPIATE DEPENDENT PATIENTS UNDERGOING A REPLACEMENT THERAPY PROGRAM IN SPAIN: THE PROTEUS STUDY Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, BUPRENOPHINE AND DUALLY DIAGNOSED OPIATE DEPENDENT PATIENTS: CLINICAL IMPLICATIONS To be confirmed TREATMENT OF DUAL DIAGNOSIS PATIENTS IN SPAIN: FEATURES AND OUTCOMES Dr. Rafael Forcada. Unit of Addictive Behaviors. Health Center San Marcelino. Valencia, Page 17

18 Room 2 13:30 15:00 CLINICAL CASE IN DUAL DIAGNOSIS AND OPIOIDS CONTEST CCC2 02 President: Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry. Hospital Universitari Vall d Hebron, Barcelona, Vicepresident: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Coordinator: Dr. Pablo Vega Astudillo. Instituto de Adicciones. Madrid, Room 2 15:00 17:00 SYMPOSIUM S2 27 DUAL DIAGNOSIS IN HEROIN AND COCAINE ADDICTS: FROM PAST TO PRESENT. CHALLENGES FOR THE FUTURE Dr. Luis Patrício. Psychiatrist. Clinical Head. Centro das Taipas IDT, Lisbon, Portugal. ADULT ADHD AND COCAINE CONSUMPTION IN HEROIN ADDICTS IN MM Dr. Juan Francisco Ramirez López. Psychiatrist. Provincial Drug Dependence and Addiction Services, Huelva, DUAL DIAGNOSIS IN HEROIN AND COCAINE ADDICTS: FROM PAST TO PRESENT. CHALLENGES FOR THE FUTURE Dr. José Pádua. Psychiatrist. IDT, IP, Lisbon, Portugal. COMORBIDITY IN PATIENTS RECEIVING OPIOID TREATMENT Dr. Antonio Felisberto. Psychiatrist, IDT CRI, Coimbra, Portugal. TREATMENT WITH OPIOIDS IN PATIENTS WITH AFFECTIVE DISORDERS AND PATIENTS WITH PERSONALITY DISORDERS Dr. Emilia Leitão. Psychiatrist. IDT ET, Loures, Loures, Portugal. TRACK 16 ALCOHOL AND DUAL DIAGNOSIS Wednesday 5th Room 11 17:30 19:00 SYMPOSIUM S1 11 NEW PHARMACOLOGICAL TREATMENTS VERSUS TRADITIONAL TREATMENTS FOR DUAL DIAGNOSIS ALCOHOLICS Dr. Eduardo Kalina. Director Psiquiatría Biológica Argentina. NEW PHARMACOLOGICAL TREATMENTS VERSUS TRADITIONAL TREATMENTS FOR DUAL DIAGNOSIS ALCOHOLICS Dr. Eduardo Kalina. Director Psiquiatría Biológica Argentina. THE CONSULTATION BECAUSE OF ALCOHOL AND DRUGS IN THE GENERAL HOSPITAL: CLINICAL PROBLEMS Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Page 18

19 NALTREXONE IN THE TREATMENT OF PATIENTS WITH SELF AGRESSIVE BEHAVIORS AND DRUG ABUSE Dr. Ricardo Rojas. Wednesday 5th Room 12 16:00 17:30 SYMPOSIUM SS1 07 ALCOHOLISM AND DUAL DIAGNOSIS Prof. Julio Bobes. Professor of Psychiatry. University of Oviedo. Wednesday 5th Room 12 17:30 19:00 SYMPOSIUM S1 12 TREATMENT OF ALCOHOLIC PATIENS PRESENTING DUAL DIAGNOSIS Dr. Josep Guardia Serecigni. Addictive Behaviors Unit. Psychiatry Service. Hospital de la Santa Creu i Sant Pau. Barcelona, TREATMENT OF ALCOHOLIC PATIENS PRESENTING DUAL DIAGNOSIS Dr. Enriqueta Ochoa Mangado. Psychiatrist. Psychiatrist. Department of Psychiatry Ramón y Cajal Hospital in Madrid. IS A SHIFT POSSIBLE IN THE PARADIGM OF ALCOHOLISM TREATMENT? Dr. Josep Guardia Serecigni. Addictive Behaviors Unit. Psychiatry Service. Hospital de la Santa Creu i Sant Pau. Barcelona, HARM REDUCTION PROGRAMS IN ALCOHOLIC PATIENTS WITH DUAL DIAGNOSIS Dr. Pedro Cuadrado Callejo. Psychiatrist. Centro de Salud Mental del Retiro de Madrid. TRACK 17 PSYCHOESTIMULANTS AND DUAL DIAGNOSIS Room 5 10:30 12:30 SYMPOSIUM S2 18 DUAL DIAGNOSIS AND STIMULANTS (COCAINE, PACO, PASTA, BASE) IN THE CITY OF BUENOS AIRES, ARGENTINA Dr. José Capece, Casa Tomada Buenos Aires, Argentina. MOTIVATIONAL INTERVIEWING AND DUAL DIAGNOSIS: THERAPEUTIC ALTERNATIVE FOR RESISTANT CASES Lic. Maximiliano Fanton. CONICET, Buenos Aires, Argentina. BIPOLARITY AND COCAINE: UPDATES IN DRUG TREATMENT IN THE PORTEÑO CONTEXT Dr. Federico Pavlovsky, Casa Tomada Buenos Aires, Argentina, ATTENTION DEFICIT DISORDER AND SUBSTANCE USE: TREATMENT DIFFICULTIES Dr. José Capece, Casa Tomada Buenos Aires, Argentina. INTERDISCIPLINARY TEAMS IN THE TREATMENT IN VULNERABLE COMMUNITIES OF PACO ADDCITS OF THE CITY OF BUENOS AIRES Page 19

20 Dr. Ignacio O Donnell, Ministerio de Desarrollo Social, Ciudad de Buenos Aires, Argentina. Room 5 12:30 14:30 SYMPOSIUM S2 23 PSYCHOSTIMULANTS IN DUAL PATIENTS Prof. Javier Álvarez. Pharmacology Department. University of Valladolid. PSYCHOSTIMULANTS DETOX IN DUAL PATIENTS Dr. Lara Grau López. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, GROUP APPROACH FOR PSYCHOSTIMULANT DEPENDENCE Dr. Oriol Esculies. Director Projecte Home Catalunya. Barcelona, PSYCHOTIC CLINIC IN COCAINE AUTOINJECTORS Dr. Nieves Martínez Luna. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, Room 15 16:00 17:30 SYMPOSIUM S2 30 COCAINE MANAGEMENT AND DUAL DIAGNOSIS: A BRIDGE BETWEEN RESEARCH AND CLINICAL PRACTICE Dr. Joan Colom i Farran. Subdirección General de Drogodependencias. Departament de Salut Catalunya. Barcelona, CLINICAL PRACTICE GUIDELINES. GPC METHODOLOGY OF COCAINE Dr. Ivan Solà. Centro Chrocane Iberoamericano. Barcelona, NEW LINES OF RESEARCH PROPOSALS AND TREATMENT OF COCAINE DEPENDENCY AND DUAL DIAGNOSIS Dr. Miquel del Rio. Psychiatry Department. Hospital Mutua de Terrasa. Barcelona, PILOT PROJECTS IN CATALONIA ON THE OUTPATIENT TREATMENT OF COCAINE DEPENDENCE Dr. Marta Coronado. Subdirección General de Drogodependencias. Departament Salut Catalunya. Barcelona, TRACK 18 CANNABIS AND DUAL DIAGNOSIS Wednesday 5th Room 8 16:00 17:30 WORKSHOP W1 02 DIFFICULT CLINICAL CASES IN DUAL DISORDERS. CANNABIS Charis: Dr. Luis Caballero. Psychiatrist Hospital de Día. Hospital Universitario Puerta de Hierro de Majadahonda, Madrid. Dr. Lola Baño. Psychiatrist. CAID Majadahonda, Madrid. MOOD DISORDERS (FIRST PSYCHOTIC EPISODE) AND CANNABIS ABUSE Page 20

21 Dr. Lidia Fernández Mayo. Clínica Doctor León. Madrid, CANNABIS PSYCHOSIS AND DISSOCIATIVE EPISODE FOR VARENICLINE Dr. Marisa Martín Calvo. Hospital Universitario Infanta Elena. Madrid, DIFFICULTY OF DIAGNOSIS AND TREATMENT OF FIRST EPISODE PSYCHOTIC ASSOCIATED TO CANNABIS DEPENDENCE Dr. Clara Pelaéz Fernandez. CSM Villalba. Universitario Puerta de Hierro. Madrid, Room 1 15:30 17:00 SYMPOSIUM S3 51 CANNABIS: PSYCHOSIS OR NEUROTOXICITY Chairs: Dr. Rocío Martín Santos. Department of Psychiatry. Hospital Clínic. Institute Clínic of Neuroscience. IDIBAPS, CIBERSAM. Barcelona, Dr. Sagnik Bhattachryya. Department of Psychosis Studies. Institute of Psychiatry. King s College. London, UK. GENETIC MODULATION OF THE NEUROCOGNITIVE EFFECTS OF CANNABIS IN MAN? Dr. Sagnik Bhattachryya. Department of Psychosis Studies. Institute of Psychiatry. King s College. London, UK. CANNABIS, PSYCHOSIS AND INTER SUBJECT VARIABILITY? Dr. Zerrin Atakan. MD, PhD, Psychosis. Institute of Psychiatry. King s College. London, UK. CHRONIC CANNABIS USERS, NEUROIMAGING AND COMT MODULATION. Dr. Rocío Martín Santos. Department of Psychiatry. Hospital Clínic. Institute Clínic of Neuroscience. IDIBAPS, CIBERSAM. Barcelona, INTERACTION BETWEEN COMT HAPLOTYPES AND CANNABIS IN SCHIZOPHRENIA Prof. Julio Sanjuan, MD, PhD, Hospital Clínic, UV, CIBERSAM. Valencia, Room 9 16:00 17:30 SYMPOSIUM S3 56 CANNABIS CONSUMPTION IN FIRST PSYCHOTIC EPISODES Dr. Judith Usall Rodié. Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat. Barcelona. CIBERSAM, Spain GENETIC VULNERABILITY, CANNABIS USE AND ITS RELATIONSHIP WITH PSYCHOSIS Dr. Mar Fatjó Vilas. Unitat d'antropologia, Departament de Biologia Animal. Facultat de Biologia, Universitat de Barcelona. IBUB. CIBERSAM. COGNITION AND CANNABIS IN FIRST EPISODE PSYCHOTIC INDIVIDUALS: COGNITION AND CANNABIS IN FIRST EPISODE PSYCHOSIS Dr. Roberto Rodríguez Jiménez. Hospital Universitario 12 de Octubre. Universidad Complutense. CIBERSAM Madrid. RELATIONSHIP BETWEEN CANNABIS CONSUMPTION AND COGNITION, EVOLUTION AND FUNCTIONING IN FIRST PSYCHOTIC EPISODES Dr. Sara Barbeito Resa y Dra Sonia Ruiz de Azua. Unidad de Investigación en Psiquiatría, Hospital Santiago Apóstol. CIBERSAM. Vitoria Gasteiz, Page 21

22 CLINICAL AND FUNCTIONING DIFFERENCES IN CANNABIS USE IN FIRST EPISODE PSYCHOSIS Dr. Susana Ochoa Güerre, Unidad de Investigación y Desarrollo de Parc Sanitari Sant Joan de Déu, Barcelona. CIBERSAM. Room 1 17:00 18:30 SYMPOSIUM S3 57 CANNABIS AND DUAL DIAGNOSIS Dr. Miguel Bernardo. Psychiatry Service. Hospital Clinic. Universitat de Barcelona. CANNABIS USE AND MENTAL ILLNESS IN A SOCIETY OF HUNTERS AND COLLECTORS (THE HATZABE) Dr. Luis Caballero. Psychiatry Department. Hospital Puerta de Hierro. Madrid, INFLUENCE OF DUAL DIAGNOSIS IN THE TERAPEUTIC ADHERENCE IN CANNABIS ADDICTS Dr. Begoña Gonzalvo. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, CANNABIS CONSUMPTION AND MENTAL DISORDERS Dr. Amine Benyamina. Centre d Enseignement, de Recherche et De Traitement des Addictions. Hôpital Universitaire Paul Brousse. Villejuif, France. TRACK 19 TOBACCO AND DUAL DIAGNOSIS Wednesday 5th Room 9 16:00 17:30 SYMPOSIUM S1 10 SMOKING IN MENTAL HEALTH AND ADDICTION SETTINGS Dr. Sílvia Mondon. Psychiatrist. Alcohol Unit, Department of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SMOKING TREATMENT IN PSYCHIATRIC PATIENTS Dr. Antònia Raich. Psychologist. Mental Health Division. Xarxa Assistencial Althaia. Manresa. VARENICLINE TREATMENT FOR SMOKING CESSATION IN ADDICTION AND MENTAL HEALTH PATIENTS Dr. Mª Cristina Pinet. Unit of Addictive Behaviors. Psychiatry Service. Hospital Santa Creu i Sant Pau. Barcelona, SECOND HAND SMOKE IN MENTAL HEALTH AND ADDICTION UNITS Dr. Montse Ballbè. Psychologist. Catalan Network of Smoke free Hospitals, Institut Català d'oncologia. Hospital Clínic de Barcelona. Barcelona. Wednesday 5th Room 8 17:30 19:00 SYMPOSIUM S1 80 HUMAN MODELS IN TOBACCO AND ITS RELATIONSHIP WITH DUAL DIAGNOSES Page 22

23 Prof. Robert West. Department of Epidemiology and Public Health. University College London, UK. TOBACCO ADDICTION AND CANNABIS CONSUMTION AND DUAL DISORDERS Dr. Arkaitz Colina. DEPENDENCIA DE TABACO Prof. Benedicto Crespo. Universidad de Santander, España. DEPENDENCIA DE TABACO Y SOMATIZACIONES Dr. García Campayo. Liaison Psychiatry Service and Psychosomatics. Hospital Clinico Universitario. Zaragoza, Wednesday 5th Room 9 17:30 19:00 WORKSHOP W1 06 IMPLEMENTING A SMOKE FREE PSYCHIATRIC UNIT Chairs: Dr. Margarita Cano. Drug Addiction Care Center. Psychiatry Service. Hospital de Mataró. Barcelona. Dr. Sílvia Mondon. Psychiatrist. Alcohology Unit. Hospital Clínic de Barcelona. Barcelona. Room 3 09:30 11:30 WORKSHOP W2 07 INTEGRATING SMOKING PROHIBITION IN PSYCHIATRIC UNITS: A COMPLEX BUT NOT IMPOSSIBLE GOAL Chairs/Presenters: Dr. Nelson Feldman. Psychiatrist, MD, associate physician, Addictionology Service, University Hospital of Geneva, Switzerland. Dr. Sophia Achab. Psychiatrist. Head of clinic. Addictionology Service. University Hospital of Geneva. Switzerland. Room 12 11:30 13:00 SYMPOSIUM S2 33 TOBACCO CONSUMPTION AND PSYCHIATRIC PATHOLOGY: AN UPDATE OF THE SELF MEDICATION HYPOTHESIS Prof. Miguel Gutiérrez Fraile. Professor of Psychiatry. University of the Basque Country. Head of Psychiatry. Hospital Santiago Apóstol. Osakidetza. Vitoria & CIBERSAM Mental Health Network. DEPRESSED AND SMOKER OR SMOKER AND DEPRESSED. SELF MEDICATION OR COMORBIDITY Dr. José Martínez Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, THE COGNITIVE APPROACH TO SELF MEDICATION HYPOTHESIS IN SCHIZOPHRENIA Dr. Arantzazu Zabala. University of the Basque Country. Center for Biomedical Research CIBERSAM Mental Health Network. Vizcaya, Page 23

24 SMOKING AND NEUROCOGNITION IN THE EUTHYMIC PHASE OF BIPOLAR DISORDER Dr. Vicent Balanzá. Teaching Unit of Psychiatry, Department of Medicine, University of Valencia Center for Biomedical Research CIBERSAM Mental Health Network. Valencia, Room 9 12:30 13:30 SATELLITE WORKSHOP SW2 01 PHARMACOLOGICAL TREATMENT OF NICOTINE DEPENDENCE IN THE PSYCHIATRIC PATIENT Sponsored by Pfizer Dr. Antonio Terán. Coordinador del Centro Ambulatorio de Atención a Drogodependientes San Juan de Dios. Palencia, Dr. Eugeni Bruguera. Psychiatry Service. Hospital Universitari Vall d Hebron. Barcelona, Dr. José Antonio Navarro Sanchis. Psychiatry Service. Hospital Universitari Vall d Hebron, Barcelona, Room 9 13:30 14:30 WORKING LUNCH GAD, TOBACCO AND SUBSTANCE ABUSE: EPIDEMIOLOGICAL ANC CLINICAL IMPLICATIONS Sponsored by Pfizer Dr. Javier García Campayo. Liaison Psychiatry Service and Psychosomatics. Hospital Clinico Universitario. Zaragoza, Dr. Eugeni Bruguera. Psychiatry Service. Hospital Universitari Vall d Hebron. Barcelona, Room 9 15:30 17:00 SYMPOSIUM S2 29 PSYCHIATRIC DISORDERS AND TOBACCO SMOKING Prof. Manuel Gurpegui, Department of Psychiatry and Institute of Neurosciences, University of Granada, Granada, CORRELATES OF SMOKING AND OF NICOTINE DEPENDENCE IN NON PSYCHIATRIC POPULATION Dr. José María Martínez Ortega. Department of Psychiatry and Institute of Neurosciences, University of Granada. NICOTINE DEPENDENCE AND DEPRESSION: A COMPLEX RELATIONSHIP Dr. Eugeni Bruguera. Psychiatry Service. Hospital Universitari Vall d Hebron. Barcelona, TOBACCO SMOKING IN PATIENTS WITH BIPOLAR DISORDER: ASSOCIATION WITH MEANINGFUL VARIABLES Dr. Luis Gutiérrez Rojas. Community Mental Health Unit, Servicio Andaluz de Salud, Loja, Page 24

25 SCHIZOPHRENIA AND SMOKING: BETWEEN SHARED VULNERABILITY AND SEL MEDICATION Prof. Manuel Gurpegui. Department of Psychiatry and Institute of Neurosciences, University of Granada. TRACK 20 USEFUL PSYCHOTROPIC DRUGS AND DUAL DIAGNOSIS Wednesday 5th Room 3 16:00 17:30 WORKSHOP W1 01 THE AMERICAN EXPERIENCE: MODEL OF INTEGRATION BETWEEN PSYCHOPHARMACOLOGY INTERVENTION AND CLINICAL GROUP PSYCHOTHERAPY PRACTICE Dr. Ricardo Restrepo Guzmán, M.D., M.P.H. Director, The Addiction Psychopharmacology Clinic at The Addiction Institute of New York. USA. FIRST STEP MODEL: INTEGRATED PSYCHOTHERAPY WITH CO OCCURRING DISORDED CLIENTS Dr. Claudia Arlo, LCSW, CGP. Clinician/Coordinator, First Step Program at The Addiction Institute of New York. USA. INTEGRATED OFFICE BASED TREATMENT: THE CONCEPT OF AN ADDICTION PSCHOPHARMACOLOGY CLINIC Dr. Ricardo Restrepo Guzmán, M.D., M.P.H. Director, The Addiction Psychopharmacology Clinic at The Addiction Institute of New York. USA. Wednesday 5th Room 3 17:30 19:00 WORKSHOP W1 04 MANAGEMENT OF THE PATIENT WITH DUAL DIAGNOSIS IN HOSPITAL EMERGENCY DEPARTMENT Dr. Helen Dolengevich Segal. Hospital de Henares. Madrid, DILEMMAS IN THE MANAGEMENT OF PATIENTS WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Helen Dolengevich Segal. Hospital de Henares. Madrid, THE PSYCHOTIC PATIIENT WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Fernando Mora Mínguez. Hospital Infanta Leonor. Madrid, THE AGITATED PATIENT WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Javier Correas Lauffer. Hospital de Henares. Madrid, THE PATIENT WITH EATING DISORDERS AND DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Rodrigo Puente García. Hospital de Henares. Madrid, CHILDREN AND ADOLESCENTS WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Prof. Javier Quintero Gutiérrez del Álamo. Hospital Infanta Leonor. Madrid, Page 25

26 Room 3 15:30 17:30 SATELLITE SYMPOSIUM SS3 05 FUTURE PHARMACOLOGICAL ADVANCES IN THE TREATMENT OF ADHD Sponsored by Shire Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry., Hospital Universitari Vall d Hebron, Barcelona, TREATMENT OF ADHD PATIENTS WITH SUBSTANCE ABUSE Dr. Mats Johnson. Gillberg Centre. University of Gothenburg. Sweden. FUTURE STIMULANT DRUGS FOR THE ADHD TREATMENT Dr. César Soutullo. Head of Child Psychiatry at the University Hospital of Navarra. FUTURE NON STIMULANT DRUGS FOR THE ADHD TREATMENT Dr. Josep Antoni Ramos Quiroga. ADHD Program Coordinator. Psychiatry Service. Hospital Universitari Vall d'hebron. Barcelona, SYMPOSIUM S3 63 DRUGS IN DUAL DIAGNOSIS Prof. Carmen Leal. University of Valencia. PSYCHOLOGICAL PROFILE OF PAINKILLERS DEPENDENT SUBJECTS Mrs. Susana Gómez Baeza. CAS. Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron. Barcelona, BENZODIAZEPINE DEPENDENCE AND DUAL DIAGNOSIS Dr. Gonzalo Haro. Dual Disorders Program. Hospital of Castellón. BENZODIAZEPINE ABUSE IN PATIENTS WITH SEVERE MENTAL DISORDERS Dr. Carmen Barral. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron. Barcelona, TRACK 21 PSYCHOPHARMACOLOGICAL TREATMENT IN DUAL DIAGNOSIS Room 3 14:00 15:30 SYMPOSIUM S3 49 PHARMACOTHERAPY ADVANCES OF DUAL DIAGNOSIS Dr. Iván Montoya. Clinical Director of Pharmacotherapies and Medical Consequences of Drug Abuse. National Institute on Drug Abuse (NIDA). Bethesda, Maryland, USA. TRACK 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS Room 2 17:00 18:30 SYMPOSIUM S3 58 SOCIAL DETERMINANTS AND DUAL DIAGNOSIS Page 26

27 Prof. John Fox. Douglas College. New Westminster, Canada. THE SOCIAL DETERMINANTS OF HEALTH: RECOVERY AND RELAPSE PREVENTION IN REAL TIME Prof. John Fox. Douglas College. New Westminster, Canada. PSYCHOTHERAPEUTIC TREATMENTS IN DUAL DISORDERS. DIALECTICAL BEHAVIORAL THERAPY AND MOTIVATIONAL INTERVIEWING IN PATIENTS WITH DUAL DIAGNOSIS Dr. Susana E. Mendez. MAOM, LCDC, CAS, ABMPP, NBCHH, ENTERHEALTH, LLC. USA. DUAL DIAGNOSIS AND MENTAL DISORDERS IN SUBSTANCE USING INMATES María José Casares López. Psychologist. University of Oviedo. Room 4 14:00 15:30 WORKSHOP W3 11 SPECIFIC CONTROL TECHNICS OF POST TRAUMATIC PATIENTS WITH DUAL DIAGNOSIS Mrs. Sara Guila Fidel Kinori. Psicóloga Clínica. Psychiatry Service. Hospital Universitari Vall d Hebron, Barcelona, Anna Giannoni Pastor. Post Traumatic Stress Disorder Program. Psychiatry Service. Hospital Universitari Vall d Hebron, Barcelona, Ruth Tasqué Cebrian. Post Traumatic Stress Disorder Program. Psychiatry Service. Hospital Universitari Vall d Hebron, Barcelona, Francisco José Eiroa Orosa, Post Traumatic Stress Disorder Program. Psychiatry Department, Hospital Universitari Vall d'hebron. Universidad Autónoma de Barcelona. Room 5 14:00 15:30 WORKSHOP W3 29 GRIEF WORK AND RECONSTRUCTION OF MEANING IN THE PSYCHOTHERAPEUTIC APPROACH IN DUAL DISORDERS Chair/Presenter: Mr. Ignacio González Jiménez. Psychologist. Addictive Behavior Unit of Villena. Valencia Health Agency. Villena, Alicante, Room 8 14:00 15:30 WORKSHOP W3 30 THERAPEUTIC STRATEGIES AND COMMUNICATION SKILLS. PERSONALIZED ECLECTIC PSYCHOTHERAPY Chair/Presenter: Mr. Maximino Portela Freire. Director of the Unidad Asistencial de Drogodependencias, Cangas, Pontevedra, WORKSHOP W Page 27

28 Room 11 15:30 17:00 WORKING WITH EMOTIONS IN THE REHABILITATION OF ADDICTIVE DISORDERS Chair/Presenter: Prof. Humberto Guajardo Sáinz. Professor of Psychiatry. Unidad de Adicciones Facultad de Ciencias Médicas University of Santiago de Chile. Room 4 15:30 17:30 SYMPOSIUM S3 81 DUAL DIAGNOSIS AND THERAPY GROUP TREATMENT To be confirmed A PRELIMINARY EXPLORATION OF AN OUTPATIENT DUAL DIAGNOSIS RECOVERY GROUP PROGRAMME Mr. John Chilton Royal College of Nursing, Progress UK, Visiting lecturer at the University of Gloucester, and the University of the West of England. AMBULATORY GROUP THERAPY FOR DUAL BIPOLAR PATIENTS Diana Bachiller. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, COMORBIDITY INFLUENCE ON THE MANAGEMENT OF CONTIGENCY IN ADDICTS Prof. Roberto Secades. University of Oviedo, Room 4 09:30 11:00 WORKSHOP W4 16 SOCIAL COMPETENCE TRAINNING AND CHANGE PROCESS Dr. A. Rita Martín Caballero. Clinical Psychologist ACJ SAN MIGUEL Collaborative Professor of ULL. Tenerife, TRAINING PROGRAMS R & R2 IN SHORT VERSION FOR ADULTS, PROMOTE SOCIAL COMPETENCES AND CHANGE Dr. A. Rita Martín Caballero. Clinical Psychologist ACJ SAN MIGUEL Collaborative Professor of ULL. Tenerife, IMPORTANCE OF SOCIAL COMPETENCE PROGRAMS IN MENTAL HEALTH Prof. Juan Martínez Torvisco. Department of Social and Organizational Psychology, University of La Laguna. Tenerife, THE EXPERIENCE OF APPLYING A SHORT PROGRAM FOR THE PREVENTION OF RELAPSE TO DRUG ADDICTS WITH MENTAL DISORDERS ASSOCIATED Román Morales de Armas and Mónica Gómez Pérez. University of La Laguna. Tenerife, Room 4 12:30 14:00 WORKSHOP W4 24 FAMILY INTERVENTION IN DUAL DIAGNOSIS Prof. Antonio Labad Alquézar. Professor of Psychiatry at the University Rovira i Virgili. Director of the teaching unit of the Hospital Psiquiátrico Universitario Institut Pere Mata. Reus. Tarragona, Page 28

29 DUAL DIAGNOSIS: FROM PATIENT TO FAMILY, A REVIEW FROM CLINICAL PRACTICE Dr. Blas Torrente Gutiérrez. Dual Diagnosis Unit. Hospital Psiquiátrico Universitario Institut Pere Mata. Reus. Tarragona, EVALUATION OF FAMILY DYNAMICS IN PATIENTS ADMITTED TO A DUAL DISORDERS HOSPITALARY TREATMENT UNIT Dr. Samuel Pombo Chorto, Dual Diagnosis Unit. Hospital Psiquiátrico Universitario Institut Pere Mata. Reus. Tarragona, Room 5 11:00 12:30 WORKSHOP W4 20 DESIGNING AND IMPLEMENTING CONTINGENCY MANAGEMENT INTERVENTIONS FOR ADDICTIVE BEHAVIORS Chairs/Presenters: Carla J. Rash. University of Connecticut Health Center. Department of Medicine. Farmington, USA. Nancy M. Petry. University of Connecticut Health Center. Department of Medicine. Farmington, USA. Room 5 12:30 14:00 WORKSHOP W4 25 EFFECTIVE TOOLS OF POSITIVE PSYCHOLOGY, RESILIENCE AND ETHICS FOR DUAL DIAGNOSIS PSYCHOEDUCATIONAL PROGRAM Dr. Guillermo Fernández Dadam. Director of Addictions and Positive Psychology, Neuropsychiatric Institute. Universidad Católica de Cuyo. Argentina. FROM HETERONOMY TO AUTONOMY LOOKING RESPONSIBILITY IN DUAL DIAGNOSIS Lic Hilda Tevez. Psychologist, Ethics and Drug Addiction. Association of Psychiatrists (APSA), Behavioral Addictions Institute of Neuropsychiatry and Positive Psychology. Buenos Aires, Argentina. 12 KEY STRATEGIES FOR THE PROMOTION OF SKILLS AND TECHNIQUES IN THE PATIENT AND FAMILY Dr. Guillermo Fernández Dadam. Addictions Institute of Neuropsychiatry and Positive Psychology. Buenos Aires, Argentina. TRACK 23 MULTIDISCIPLINARY APPROACHES Room 12 09:30 11:30 SYMPOSIUM S2 16 DUAL CARE. DIVERSITY OF MODELS OF INTERVENTION IN DUAL DIAGNOSIS IN THE AUTONOMIES IN SPAIN Dr. Carlos Álvarez Vara. Comisión Clínica de la Delegación del Gobierno para el Plan Nacional sobre Drogas. Madrid, Page 29

30 UN ORIGINAL MODELO GALLEGO Dr. Víctor Pedreira. Head of Psychiatry, Complejo Hospitalario de Pontevedra, LA SORPRENDENTE EXPERIENCIA DE MURCIA Dr. Juan Jiménez Rosset. Responsable del Plan de Drogodependencias. Murcia, LA PECULIAR HISTORIA DE LA SALUD MENTAL EN NAVARRA Dr. Fermín Castiella. Director del Programa de Drogodependencias del Gobierno de Navarra, Room 1 14:00 15:30 SYMPOSIUM S3 50 SPECIFIC APPROACHES TO PATIENTS WITH DUAL DIAGNOSIS Sponsored by the Portuguese Association of Dual Pathology Dr. Célia Franco. Psychiatrist. Coordinator of the Addiction Service (SA) of CHPC. APPD s President. Portugal. APPROACH AND TREATMENT OF ADDICTED AND DUAL DIAGNOSED PATIENTS IN PORTUGAL Dr. Carla Silva. Psychiatrist and Dr. Célia Franco. Psychiatrist. Coordinator of Addiction Service (SA) CHPC. President APPD. Portugal. PSYCHOTHERAPY IN PATIENTS WITH DUAL DIAGNOSIS Dr. Vera Raposo. Clinical Psychologist of SA. Bureau of APPD. Portugal. THE ROLE OF NURSES IN THE MULTIDISCIPLINARY TEAM MANAGING DUAL DIAGNOSIS PATIENTS Dr. Vladimiro Andrade. Nurse Chief of SA. Vice President of APPD. Portugal. Room 6 15:30 17:00 SYMPOSIUM S3 61 TOWARDS INTEGRATED DUAL DISORDER TREATMENT IN THE NETHERLANDS Dr. Sonja van Rooijen, Projectleader LEDD, Senior Research Associate. Trimbos Institute. Utrecht, The Netherlands. IMPLEMENTING INTEGRATED TREATMENT IN THE NETHERLANDS, THE DUTCH EXPERIENCE Mrs. Anneke van Wamel. Research Associate. Programme Reintegration Trimbos Institute. Utrecht, The Netherlands. THE NEED FOR A NATIONAL CENTRE OF EXPERTISE ON DUAL DISORDER Mr. Bas van der Hoorn. Psychiatrist. Palier, part of Parnassia Bavogroep. The Hague, The Netherlands. INTEGRATED TREATMENT FOR PATIENTS WITH PERSONALITY DISORDERS AND ADDICTION Mr. Albert Dijkhuizen. Psychiatrist, GGz Eindhoven en de Kempen Eindhoven. The Netherlands. GROUP TREATMENT FOR DUAL DISORDER PATIENTS Mrs. Martje van Giffen. Projectmanager Dual Disorders. Mentrum, part of Arkin. Amsterdam, The Netherlands. HOUSING FOR DUAL DISORDER PATIENTS IN THE NETHERLANDS Page 30

31 Mrs. Christien Muusse. Research associate. Programme Reintegration. Trimbos Institute. Utrecht, The Netherlands. Room 8 15:30 17:00 SYMPOSIUM S3 82 DRUG AND ALCOHOL IMPACT IN EMERGENCIES IMPACTO DE DROGAS Y ALCOHOL SOBRE LAS URGENCIAS Dr. Frutos del Nogal Sáez. Medical Specialist in Intensive Care. Intensive Care Service.Hospital Universitario Severo Ochoa. Leganés, Madrid, DESIGNER DRUGS AND PHARMING IN HOSPITAL EMERGENCIES Dr. Miguel Galicia. Emergency Department. Hospital Clinic. Barcelona, DRUGS AND ALCOHOL IN POLITRAUMA PATIENTS Dr. Emilio Alted López. Specialist in intensive care. Head of the trauma patients. Intensive Care Service. Hospital Universitario 12 de Octubre. Madrid, Room 3 09:30 11:00 WORKSHOP W4 15 THE TRANSLATION OF DUAL DIAGNOSIS THEORY TO CLINICAL PRACTICE WITH UNDERGRADUATE STUDENT NURSES: THE AUSTRALIAN EXPERIENCE Chairs/Presenters: Mr. Richard Bostwick. Course Coordinator/Senior Lecturer (Mental Health). School of Nursing, Midwifery and Postgraduate Medicine Edith Cowan University, Perth, Western Australia. Dr. Michael Monisse Redman. Lecturer (Mental Health). School of Nursing, Midwifery and Postgraduate Medicine Edith Cowan University, Perth, Western Australia. Room 9 09:30 11:00 SYMPOSIUM S4 65 RESEARCH AND THERAPEUTIC APPROACH TO ADDICTIVE PATHOLOGY IN MEXICO Dr. Mario Souza y Machorro. Academia Mexicana de Patología Dual. Mexico City, Mexico. ADDICTIVE PATHOLOGY CO MORBID TO ANXIETY DISORDERS. PSYCHOPATHOLOGY AND TREATMENT Dr. Mario Souza y Machorro. Academia Mexicana de Patología Dual, AMEPAD. Ciudad de México. Mexico. DUAL DISORDER IN MEXICO UNIVERSITY STUDENTS WITH ALCOHOL DEPENDENCE Lic. Rosa Díaz Martínez. Psychiatry and Mental Health Department. Faculty of Medicine of the Universidad Nacional Autónoma de México. Mexico. MIRTAZAPINE IN ADOLESCENTS AND YOUNG ADULTS WITH PROBLEMATIC ALCOHOL CONSUMPTION AND MAJOR DEPRESSION: A CONTROLLED CLINICAL TRIAL Dr. Carlos Hernández Ávila. Psychiatry and Mental Health Department. Page 31

32 Faculty of Medicine of the Universidad Nacional Autónoma de México. Mexico. COGNITIVE BEHAVIORAL THERAPY COMBINED WITH BUPROPION EXTENDED RELEASE FOR RELAPSE PREVENTION IN THE PROCESS OF QUITTING Dr. Jorge Ocampo. Academia Mexicana de Patología Dual, AMEPAD. Mexico City, Mexico. Room 10 09:30 11:00 WORKSHOP W4 17 DUAL DIAGNOSIS: DIAGNOSIS FOR DIFFERENT OR THE SAME ISSUES Dr. Luciano Cobos Luna. Doctor Coordinator. Drug and Addictions Instituto Provincial de Bienestar Social. Córdoba, DUAL DIAGNOSIS AND EXPERIMENTAL COMMON ELEMENTS Dr. Bartolomé Marín Romero. Psychologist. Los Pedroches. Villanueva de Córdoba Drugs and Addiction Clinic. Córdoba, PHARMACOLOGY AND DUAL DIAGNOSIS Dr. Francisco Ignacio Mata Cala. Doctor. Psychiatrist. Vega del Guadalquivir Drugs and Addiction Clinic. Córdoba, Spain COGNITIVE THERAPY IN DUAL PATHOLOGY. FUTURE PERSPECTIVES Dr. Magdalena de Miguel Fernández. Psychologist. Córdoba Centro Drugs and Addiction Clinic. Córdoba, Room 12 09:30 11:00 WORKSHOP W4 19 HOSPITAL ADDICTIONS. DUAL DIAGNOSIS Chair/Presenter: Dr. Victor Puente Pazos. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria Gasteiz. Basque Country, RELAPSE PREVENTION GROUP DAY HOSPITAL IN DUAL DIAGNOSIS Dr. Juan Miguel Llorente del Pozo. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria Gasteiz. Basque Country, SOCIAL WORK IN THE DAY HOSPITAL OF ADDICTIONS. DUAL DIAGNOSIS Dr. Fernando Manzanos Ruiz de Eguino. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria Gasteiz. Basque Country, DAY HOSPITAL IN ADDICTIONS. DUAL DIAGNOSIS Dr. Victor Puente Pazos. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria Gasteiz. Basque Country, CLINICAL PRACTICE IN THE DAY HOSPITAL FOR DUAL DIAGNOSIS Dr. Ana Isabel Ramírez Gorostiza. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria Gasteiz. Basque Country, Room 9 11:00 12:30 SYMPOSIUM S4 70 ADDICTIVE BEHAVIORS AND OTHER MENTAL DISORDERS IN ILLEGAL DRUG USERS IN DEPREVIED SOCIAL SITUATION Page 32

33 Dr. Pere Antoni Soler Insa. Psychiatric Area Director of the Hospital Universitari Mutua Terrassa. Drug Addiction and AIDS Management Area. Cruz Roja Barcelona. PSYCHIATRIC DISORDERS IN LON TERM HEROIN AND COCAINE USERS Dr. Jorge Fernández López. CEA MARITIM (Comité Ciudadano Anti SIDA de la Comunidad Valenciana). Valencia, PSYCHIATRIC MANIFESTATIONS IN THE ACUTE POST COCAINE USE SYNDROME Dr. Lorena Andreo Pagan. SAPS Creu Roja. Barcelona. In colaboration with the Injection Rooms from Barcelona, LLeida, Bilbao and Madrid, CONVULSIVE SYNDROME AND DRUG USE Dr. Anna Planas Ballvé. Hospital Universitari del Sagrat Cor. Barcelona, CARE OF DRUG USERS WITH PSYCHIATRIC SYMPTOMATOLOGY IN A NON SPECIALIZED SERVICE Dr. Ana Altabas Reñé. AMBIT Prevenció. Barcelona. ALTER PSICHIATRY: ANOTHER MODEL OF CARE FOR PATIENTS WITH DRUG PROBLEMS Mrs. Olga Díaz Grau. Centre Integral Lluis Companys. Creu Roja Barcelona. Room 10 11:00 12:30 WORKSHOP W4 21 COMUNIDAD TERAPEUTICA Y PATOLOGIA DUAL Lic. Daniel De Angelis, President of the Proyecto Uno, Comunidad Terapéutica en Adicciones y Salud Mental. Buenos Aires, Argentina. CONCEPTUALIZATION AND DEVELOPMENT OF AN INTEGRAL THERAPEUTIC COMMUNITY Lic. Daniel De Angelis. Proyecto Uno. Buenos Aires, Argentina. STRATEGIES OF INTERVENTION IN AN INTEGRAL THERAPEUTIC COMMUNITY FOR PATIENTS WITH DUAL DIAGNOSIS Lic. Sebastián Rodríguez. Proyecto Uno. Buenos Aires, Argentina. Room 12 11:00 12:30 WORKSHOP W4 22 DUAL DISORDER GROUP TREATMENT Challenging but worthy of further exploration Chair/Presenter: Martje van Giffen. Project leader, Integrated Dual Disorder Treatment, Mentrum, mental health care and addiction treatment, part of Arkin, Amsterdam, The Netherlands. Room 9 12:30 14:00 SYMPOSIUM S4 74 MULTIDISCIPLINARY MANAGEMENT OF DUAL PATHOLOGY COMMUNITY THERAPEUTIC FOR TREATMENT OF ADDICTION AND AMBULATORY NETWORK. Page 33

34 EXPERIENCE OF TWO YEARS IN BOARDING PHARMACOLOGICAL AND PSYCHOTHERAPEUTIC AND SOCIAL Dr. Alicia Muñoz. Psychiatrist. Technical Director, Centro de Tratamiento de Adicciones "El Jaguel" de Maldonado (CETAM), Uruguay. PRESENTATION OF THE CENTER AND THE NETWORK Lic. Tatiana Scavone. Licenciada en Enfermería. Jefa de Personal del CETAM, Uruguay. EVALUATION STATISTICS Lic. Diana Mirabal. Licenciada en Servicio Social del CETAM y Equipo de Gestión. Uruguay. EXPERIENTIAL, THE UNDERSCORE AND CONCLUSIONS Lic. Adriana Ruiz. Psicóloga del CETAM y equipo de Gestión, Uruguay. Room 12 12:30 14:00 WORKSHOP W4 28 IMPLEMENTING INTEGRATED TREATMENT FOR DUAL DISORDERS IN THE NETHERLANDS: LESSONS LEARNED Chairs/Presenters: Mrs. Anneke van Wamel. Research Associate. Programme Reintegration, Trimbosinstitute. Utrecht, The Netherlands. Mrs. Christien Muusse. Research Associate. Programme Reintegration, Trimbosinstitute. Utrecht, The Netherlands. TRACK 24 BASIC RESEARCH IN DUAL DIAGNOSIS Room 11 11:00 12:30 SYMPOSIUM S3 37 CHRONOBIOLOGICAL ASPECTS IN DUAL PATHOLOGY Chair/Presenter: Dr. Gemma Prat. University of Barcelona y Fundación Althaia. Barcelona, Spain CHRONOBIOLOGY: METHODOLOGICAL ASPECTS Prof. Juan Antonio Madrid. University of Murcia. PSYCHOPATHOLOGY AND SLEEP WAKE CYCLE Prof. Eduard Estivill. Unitat d Alteracions del Son. Clínica Dexeus. Barcelona, CIRCADIAN RHYTHMICITY AND DUAL PATHOLOGY: CHRONOBIOLOGICAL THERAPEUTIC APPROACHES Prof. Ana Adan. University of Barcelona. Room 3 12:30 14:00 SYMPOSIUM S3 78 GENETICS AND BIOLOGICAL MARKERS IN ADDICTION AND DUAL DIAGNOSIS Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Page 34

35 Medicine. Houston, Texas, USA. COCAINE DEPENDENCE, GENETIC MARKERS Dr. Marta Ribases. Unidad de Genética Psiquiátrica. Psychiatry Service. Hospital Universitari Vall d Hebron. Barcelona, THE APOMORPHINE TEST AS A BIOLOGICAL MARKER OF RELAPSE Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, Room 11 12:30 14:00 SYMPOSIUM S3 45 PRECLINICAL RESEARCH IN ADICTIONS AND ITS CLINICAL TRASLATION IN DUAL DIAGNOSIS Prof. Emilio Ambrosio Flores. Professor. Department of Psicobiology. UNED. Madrid, ANIMAL MODELS FOR STUDYING DUAL DIAGNOSIS: EFFECTS OF ALCOHOL AND PSYCHOSTIMULANTS Prof. Olga Valverde Granados. Professor of Psicobiology. Universidad Pompeu Fabra de Barcelona. SUSCEPTIBILITY TO COCAINE ADDICTION IN AN ANIMAL MODEL OF SCHIZOPHRENIA Prof. Alejandro Higuera Matas. Department of Psicobiology. Facultad de Psicología. UNED. Madrid, ADVANCES IN THE TREATMENT OF DUAL DIAGNOSIS Dr. Iván Montoya. Clinical Director of Pharmacotherapies and Medical Consequences of Drug Abuse. National Institute on Drug Abuse (NIDA). Bethesda, Maryland, USA. Room 12 17:00 18:30 SYMPOSIUM S3 62 WHAT CAN BASIC RESEARCH ADD TO A BETTER UNDERSTAING OF DUAL DIAGNOSIS? Dr. José Antonio Ramos Atance, Professor, Department of Biochemistry and Molecular Biology, Facultad de Odontología, Universidad Complutense, Madrid, IMPLICATION OF THE ENDOCANNABINOID SYSTEM DURING THE DEVELOPMENT AND ONSET OF SCHIZOPHRENIA Prof. Ismael Galve Ropert, Professor, Department of Biochemistry and Molecular Biology. Facultad de Ciencias Biológicas. Universidad Complutense, Madrid, USE OF CANNABIS AND DRUGS OF ABUSE AT YOUNGER AGES IN RELATIONSHIP WITH AN EARLIER ONSET OF SCHIZOPHRENIA Dr. Maria Paz Viveros. Professor of University. Department of Physiology (Animal Physiology II). Faculty of Biology. Universidad Complutense. Madrid, INFLUENCE OF DRUGS OF ABUSE IN THE TREATMENT OF SCHIZOPHRENIA Page 35

36 Dr. Francisco Arias Horcajada. Psychiatry Service. Fundación Hospital de Alcorcón. Madrid, TRACK 25 SPIRITUALITY AND DUAL DIAGNOSIS Room 11 13:00 14:30 SYMPOSIUM S3 34 SPIRITUALITY AND DUAL DISORDERS Prof. Juan José López Ibor. Professor of Psychiatry. Universidad Complutense de Madrid. SPIRITUALITY AND DUAL DISORDERS Prof. Marc Galanter. Professor of Psychiatry and Director. Division of Alcoholism and Drug Abuse. NYU School of Medicine. New York, USA. ESTUDIO DE LA ESPIRITUALIDAD EN ADICTOS ESPAÑOLES Dr. Gideoni Fusté. CAS Vall d Hebron. Hospital Universitari Vall d Hebron, Barcelona, SPIRITUALITY AND IMMIGRATION Dr. Adil Qureshi. Servei de Psiquiatria. Hospital Universitari Vall d'hebron. Barcelona, Room 11 14:30 16:00 SYMPOSIUM S3 41 BASES BIOLÓGICAS DE LA ESPIRITUALIDAD EN PATIENTS CON CONDUCTAS ADICTIVAS To be confirmed BIOLOGICAL BASIS OF SPIRITUALITY IN ADDICTS Prof. Rafael Tobeña. Department of Psychiatry and Legal Medicine. Universidad Autónoma de Barcelona. WHAT IS THERE TO LEARN FOR THERAPISTS FROM SUFISM TO ENHANCE AWARENESS AND UNDERSTANDING? Prof. Mehmet Z. Sungur. President of Turkish Association of Cognitive and Behavior Psychotherapy. TRACK 26 SEXUAL DISFUNCTION AND DUAL DIAGNOSIS Wednesday 5th Room 5 16:00 17:30 SYMPOSIUM S1 04 DRUGS AND SEXUALITY Dr. Ángel Luis Montejo. Psychiatry Service. Hospital Clínico Universitario de Salamanca. SUBSTANCE ABUSE, SEXUAL DYSFUNCTION AND PHARMACOLOGICAL Page 36

37 PSYCHIATRIC TREATMENTS Dr. Ángel Luis Montejo. Psychiatry Service. Hospital Clínico Universitario de Salamanca. COCAINE, ALCOHOL AND SEXUAL ADDICTION Dr. José Antonio Navarro Sanchis. Psychiatry Service. Hospital Universitari Vall d Hebron. Barcelona, Wednesday 5th Room 5 17:30 19:00 SYMPOSIUM S1 08 SEXUAL DYSFUNCTION Prof. Michel Reynaud. Département de Psychiatrie et d'addictologie. Hôpital Universitaire Paul Brousse. Villejuif, France. SEXUAL ADDICTION AND AFFECTIVE DEPENDENCE: ITS CLINICAL SYMPTOMS AND RISK FACTORS Prof. Michel Reynaud. Département de Psychiatrie et d'addictologie. Hôpital Universitaire Paul Brousse. Villejuif, France. EMOTIONAL DEPENDENCE AND MENTAL HEALTH Dr. Francisco Cabello. TRACK 27 LEGAL ASPECTS IN DUAL DIAGNOSIS Wednesday 5th Room 2 17:30 19:00 SYMPOSIUM S1 07 THE FORENSIC PERSPECTIVE IN DUAL DIAGNOSIS Chairs: Prof. Leopoldo Ortega Monasterio. Universidad Internacional de Cataluña e IMLC. Barcelona, Dr. Esperanza L. Gómez Durán. Universidad Internacional de Cataluña y CAEM. Barcelona, IMPUTABILITY IN DUAL DIAGNOSIS Prof. Leopoldo Ortega Monasterio. Universidad Internacional de Cataluña e IMLC. Barcelona, CRIMINOLOGIC ASPECTS IN DUAL DIAGNOSIS Dr. Esperanza L. Gómez Durán. Universidad Internacional de Cataluña y CAEM. Barcelona, SAFETY MEASURES IN DUAL DIAGNOSIS Dr. Amadeo Pujol Robinat. Jefe del Servicio de Clínica Médico Forense. Institut de Medicina Legal de Catalunya. Barcelona, Room 11 15:30 17:00 SYMPOSIUM S3 77 DUAL DIAGNOSIS Y PRISIÓN Dr. Antonio López Burgos. President, Sociedad Española de Sanidad Penitenciaria. Sevilla, Page 37

38 DUAL DIAGNOSIS AND DELINQUENCY: CHARACTERISTICS OF PRISON PSYCHIATRIC CARE Dr. Manuel Sanz Cuenca. Psychiatrist, Hospital Psiquiátrico Penitenciario de Sevilla. DUAL DIAGNOSIS AND ADDICTIVE BEHAVIORS IN PRISON Dr. Pedro Seijo Ceballos. Consulting Psychiatrist, Centro Penitenciario de Sevilla. OPIOID SUBSTITUTION PROGRAMS IN PRISON, ANOTHER ALTERNATIVE TO METHADONE Dr. José Joaquín Antón Basantas. Physician, Centro Penitenciario de Albolote. Granada, Room 11 17:00 18:30 WORKSHOP W3 13 HISTORY OF FORENCIS PSYCHIATRY IN CHILE AND IN THE PSYCHIATRIC HOSPITAL PHILIPPE PINEL: A CASE OF PSYCHOSIS. Chairs/Presenters: Mrs. María José López Sepulveda. Clinical Psychologist. Hospital Psiquiátrico Philippe Pinel. San Felipe Putaendo, Chile. Mr. Cristian Magnan García. San Felipe Putaendo, Chile. TRACK 28 RESOURCE MANAGEMENT Room 2 17:00 19:00 SYMPOSIUM S2 32 TREATMENT MODELS IN DUAL DIAGNOSIS: INTEGRATED OR UNIFIED TREATMENT Dr. Carlos Álvarez Vara. Comisión Clínica de la Delegación del Gobierno para el Plan Nacional sobre Drogas. Madrid, MANAGEMENT OF CONCURRENT DISORDERS IN ADDICTION AND MENTAL HEALTH: THE ALBERTA CASE STUDY Prof. Nady el Guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. THE MODEL OF THE CITY OF MADRID Dr. José Manuel Torrecilla Jiménez. Gerente Madrid Salud. MANGEMENT OF THE DUAL PATIENT IN FRANCE. THE BIARRITZ EXPERIENCE. Dr. Jean Pierre Daulouede. Psychiatre. Directeur du center de soins. Bayonne, France. Room 3 11:00 12:30 SYMPOSIUM S4 68 INTERNATIONAL COOPERATION IN THE IMPROVEMENT OF CARE OF DUAL PATIENTS IN LATINAMERICA Dr. Luis Alfonzo, Specialist In Demand Reduction, CICAD Organización de Estados Page 38

39 Americanos. Washington, USA. Dr. Luis Alfonzo, Specialist In Demand Reduction, CICAD Organización de Estados Americanos. Washington, USA. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Dr. Edgard Belfort. Ex presidente de la APAL. University of Caracas. Venezuela. Dra. Elvia Velázquez. University of Antioquía. Colombia. Room 4 11:00 12:30 SYMPOSIUM S4 69 DUAL PATHOLOGY BY DRUG CONSUMPTION AND IN AN OUT PATIENT IN DIFFERENTS RESOURCES OF TREATMENT IN CANARY ISLANDS TO BE CONFIRMED DUAL PATHOLOGY STUDIES ON DRUG CONSUMPTION IN A SAMPLE OF PATIENTS FROM THE UAD S / C DE TENERIFE Ms. María Natividad García Gómez. Clinical Psychologist UAD S / C de Tenerife of ACJ SAN MIGUEL. Tenerife. Canary Islands, DRUG CONSUMPTION AND ASSOCIATED PSYCHIATRIC PATHOLOGY Mr. Antonio M. Rodríguez Cerezo. Clinical Psychologist and Coordinator of the UAD S/C de La Palma. Canary Islands, PSYCHOPATHOLOGICAL PROFILE AND DUAL in PATIENT IN THIRD LEVEL S TREATMENT CENTER Dr. A. Rita Martín Caballero. Clinical Psychologist of the Day Centre "Cercado del Marqués" ACJ SAN MIGUEL and Collaborative Professor of ULL. Tenerife. Canary Islands, Room 3 12:30 14:00 SYMPOSIUM S4 73 UK PERSPECTIVES IN DUAL DISORDERS SERVICE DEVELOPMENT Dr. Elizabeth Hughes. Senior Lecturer. University of York, UK. TRAINING IN DUAL DIAGNOSIS INTERVENTIONS EXPERIENCE FROM RCTS Dr. Elizabeth Hughes. Senior Lecturer. University of York, UK. DEVELOPING SERVICES AND SUPPORT FOR CARERS OF PEOPLE WITH DUAL DIAGNOSIS Dr. Tara O Neill. Consultant Clinical Psychologist. Psygroup Consulting/ C&IMHCT. Brighton, UK. DEVELOPING WORKFORCE COMPETEMCE USING INNOVATIVE LEARNING TECHNOLOGIES Mr. Justine Trippier. Consultant Nurse Mental Health & Substance Use (Dual Diagnosis). Oxleas NHS Foundation Trust. London, UK. LOW THRESHOLD MENTAL HEALTH INTERVENTIONS FOR CANNABIS USERS A PILOT GROUP PROGRAMME Mrs. Lois Dugmore. Consultant Nurse Dual Diagnosis. Leicestershire Partnership NHS Trust. Bradgate Unit. Glenfield Hospital. Leicester, United Kingdom. Page 39

40 TRACK 29 BEHAVIORAL ADDICTIONS AND GAMBLING Wednesday 5th Room 4 16:00 17:30 SYMPOSIUM S1 03 PATHOLOGICAL GAMBLING AND DUAL DIAGNOSIS Chair/Presenter: Dr. César A. Sánchez Bello. Sección de Juego Patológico y Otras Adicciones Comportamentales APAL. Unidad de Atención Integral de Juego Patológico, Hospital I.V.S.S. Luis Ortega, Porlamar, Isla de Margarita, Venezuela. PERSONALITY DISORDERS AND PATHOLOGICAL GAMBLING Dr. Enrique Echeburúa. University of País Vasco, San Sebastián, País Vasco, ANXIETY DISORDERS AND PATHOLOGICAL GAMBLING Dr. Alfredo Cía. APSA, Buenos Aires, Argentina. AFFECTIVE DISORDERS AND PATHOLOGICAL GAMBLING Dr. César A. Sánchez Bello. APAL. I.V.S.S. Porlamar, Margarita, Venezuela. ADDICTIVE DISORDERS AND PATHOLOGICAL GAMBLING Dr. Elisardo Becoña. Universidad Santiago de Compostela. Galicia, Wednesday 5th Room 4 17:30 19:00 WORKSHOP W1 05 CURRENT TENDENCIES IN THE INTEGRAL MANAGEMENT OF PATHOLOGICAL GAMBLING Chair/Presenter: Dr. César A. Sánchez Bello. Sección de Juego Patológico y Otras Adicciones Comportamentales APAL. Unidad de Atención Integral de Juego Patológico, Hospital I.V.S.S. Luis Ortega, Porlamar, Isla de Margarita, Venezuela. TRACK 30 EPIDEMIOLOGY AND DUAL DIAGNOSIS Room 2 12:30 14:00 SYMPOSIUM S3 40 EVIDENCE OF DUAL DIAGNOSIS IN THE NESARC? Dr. José Manuel Torrecilla. Manager of Madrid Salud. Madrid, EVIDENCIAS EPIDEMIOLÓGICAS DE LA DUAL DIAGNOSIS IN THE ESTUDIO NESARC Prof. Deborah Hasin. Columbia University Department of Psychiatry. New York, USA. Room 2 15:30 17:00 SYMPOSIUM S3 52 DUAL DIAGNOSIS IN THE DSM5 AND ICD11 Page 40

41 Prof. Alfredo Calcedo Barba. Hospital General Universitario Gregorio Marañón. Madrid, Prof. Nady el Guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. TRACK 31 SUICIDE Room 5 15:30 17:00 SYMPOSIUM S3 53 SUBSTANCE USE DISORDERS AND SUICIDE Chairs/Presenters: Dr. Leo Sher. Associate Clinical Professor of Psychiatry. Medical Center Columbia University. New York, USA. M. Dolores Braquehais. Psychiatry Service. Hospital Universitari Vall d'hebron. Barcelona, THE UNCOUNTED CASUALTIES OF WAR: SUICIDE IN WAR VETERANS WITH SUBSTANCE USE DISORDERS Dr. Leo Sher. Associate Clinical Professor of Psychiatry. Medical Center Columbia University. New York, USA. CHILDHOOD ABUSE, IMPULSIVITY, SUBSTANCE ABUSE AND SUICIDE Dr. M. Dolores Braquehais. Psychiatry Service. Hospital Universitari Vall d'hebron. Barcelona, MOOD DISORDERS AND SMOKING ITS RELATIONSHIP WITH SUICIDAL BEHAVIOR Dr. Zoltan Rihmer, M.D., Ph.D., Semmelweis University. Budapest, Hungary. BIPOLAR DISORDER, ALCOHOL AND SUICIDE. WHAT ARE THE RELATIONS? Dr. Brit Haver, M.D., Ph.D., University of Bergen. Norway Room 5 17:00 18:30 SYMPOSIUM S3 60 SUICIDE Prof. José Giner. Professor of Clinical Psychology. University of Sevilla, PREDICTIVE FACTORS OF SUICIDE Dr. Lucas Giner. University of Sevilla, MANAGEMENT OF SUICIDE IDEATION IN DUAL PATIENTS Diana Bachiller. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, TRACK 32 SCHOOL FAILURE Room 12 SYMPOSIUM S2 24 ACADEMIC FAILURE Page 41

42 13:00 15:00 Chairs: Dr. Cristina Pellisé. Departament de Educació. Generalitat de Catalunya. Barcelona, Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry. Hospital Universitari Vall d Hebron, Barcelona, STIMULANT USE AND SCHOOL FAILURE Dr. Rosa Bosch. Psychiatry Service. Hospital Universitari Vall d Hebron, Barcelona, SUBSTANCE USE IN CHILDREN AND ADOLESCENTS: RISK FACTORS AND PREVENTION STRATEGIES Dr. Nuria Yáñez Ferrer. Psychiatrist. Unidad de Salud Mental Infanto Juvenil (USMI) "Miguel Servet" de Benicalap. Valencia, Spain CANNABIS USE AND SCHOOL FAILURE Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry, Hospital Universitari Vall d Hebron, Barcelona, TRACK 33 SLEEP DISORDERS AND DUAL DIAGNOSIS Room 3 11:00 12:30 SYMPOSIUM S3 76 SLEEP DISORDER, PSYCOPATHOLOGY AND SUBSTANCE USE DISORDERS Dr. Miquel Roca. Psychiatry Service. Hospital Joan March. Universitat Illes Balears. SUBTANCE ABUSE AND SLEEP DISORDERS Prof. Tarek A. ASAAD. Institute of Psychiatry. Ain Shams University. Cairo, Egypt. BENZODIACEPINE DEPENDENCE AND COMORBIDITY Dr. Francesca Cañellas. Coordinadora Área de Salud Mental. Hospital Universitario Son Espases. Palma de Mallorca. SLEEP DISORDERS AND PSYCOPATHOLOGY Prof. Margaret L. Griffin. Associate Clinical Professor in Psychiatry. Harvard Medical School. McLean Hospital. Belmont, USA. DR. NORA VOLKOW S ACTIVITIES Wednesday 5th 10:00 13:00 DIALOGUE: LET S TALK ABOUT DRUGS Sponsored by Fundación La Caixa Dr. Nora Volkow. NIDA Director. Room 15 BREAKFAST WITH DR. NORA VOLKOW Invitation only access Page 42

43 08:30 10:00 Room 1 16:00 18:00 I HAVE A QUESTION FOR DR. NORA VOLKOW 09:30 11:00 MAIN LECTURE THE BRAIN AND DUAL DIAGNOSIS Dr. Nora Volkow. NIDA Director. OTHERS Wednesday 5th Room 11 16:00 17:30 BOOK PRESENTATION PL1 01 TREATING DRUG PROBLEMS. A GUIDE TO THE THERAPIST. HOW TO OVERCOME TOBACCO, ALOCHOL AND DRUGS? Miguel del Nogal Tomé. Psychologist. Drug Center Dr. Santanero. Cruz Roja. Madrid, EMOTION WORK IN ADDICTIVE DISORDERS Prof. Dr. Humberto Guajardo Sáinz. Addictions Unit, Faculty of Medical Sciences, University of Santiago de Chile, Chile. Room 8 09:30 19:00 MEETING WITH THE EXPERT ME2 01 Scientific Committee Sala 11 10:30 11:00 PRESENTATION OF THE STUDY OF THE SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL RESOURCES IN DUAL DIAGNOSIS Chairs/Presenters: Dr. Pablo Vega Astudillo. Instituto de Adicciones. Madrid, Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Room 11 11:30 13:00 SATELLITE SYMPOSIUM SS2 12 INTERVENTION PROTOCOLS IN DUAL DIAGNOSIS Sponsored por Brainpharma (Grupo Ferrer) Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Page 43

44 DUAL DIAGNOSIS IN SCHIZOPHRENIA Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d'hebron ASPB, Barcelona, DUAL DIAGNOSIS IN ANXIETY Prof. Pilar A. Sáiz Martínez. Professor of Psychiatry. Universidad Oviedo. DUAL DIAGNOSIS IN ADHD Dr. José Martínez Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Room 15 13:00 15:00 LUNCH WITH PROF. PEDRO RUIZ Invitation only access Room 11 08:00 09:00 BREAKFAST WITH THE EXPERT 09:00 09:30 INSTITUTIONAL ACT Room 6 11:00 14:00 RETHINKING THE DUAL DIAGNOSIS President: Prof. Pedro Ruiz. Psychiatry and Behavioral Sciences. University of Texas Houston Medical School. Houston, USA. Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry. Hospital Universitari Vall d Hebron, Barcelona, Dr. Nora Volkow. NIDA Director. Prof. John Strang. Professor of Psychiatry of Addictions. Director of the National Addiction Centre. London, UK. Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Prof. Nady el Guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. Dr. Gabriele Fischer Dr. Leo Sher. Associate Clinical Professor of Psychiatry. Medical Center Columbia University. New York, USA. Page 44

45 Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. Prof. Alan Green. Dr. José Martínez Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar, Universitat Autònoma Barcelona, Room 8 11:00 14:00 MEETING WITH THE EXPERT Room 9 11:00 12:30 SYMPOSIUM SI3 01 THE CHALLENGE OF PHARMACEUTICAL INDUSTRY FARMACÉUTICA IN FACE OF THE ADVANCES OF DUAL DIAGNOSIS: A NEGLECTED EVIDENCE FOR DECADES Despite the retoric of certain media, stating that any collaboration between the Scientific and Academic Community with the Pharmaceutical Industry is by definition not very ethical, this committee shares the opinion of the NIMH (National Institute of Mental Health) from the USA, on the need of collaboration between these two Interest groups jointly with the Administration, with the aim of a New Biotech focussed in attaining new and innovative therapeutic instruments for treating mental illnesses. This is the purpose and direction of this symposium organized by invitation of the Scientific Committee and the SEPD. TO BE CONFIRMED Presenters: Mr. Eric Patrouillard. President Lilly, Mrs. Elvira Sanz. President Pfizer, Mr. Martín Selles. President Janssen, Room 6 14:00 15:00 LUNCH WITH THE EXPERT USE AND CLINICAL EXPERIENCE OF PROLONGED RELEASE NOVEL ANTIPSYCHOTICS Sponsored by Lilly Room 12 14:00 15:30 SATELLITE SYMPOSIUM SS3 06 TOWARDS A PSYCHIATRIC CARE OF EXCELLENCE Sponsored by Neurofarmagen Dr. Salvador Ros. Hospital del Mar. Universidad Autónoma de Barcelona. ClLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS Page 45

46 ATTENDING A PSYCHIATRIC PRIVATE PRACTICE. (PRELIMINARY DATA FROM THE FIRST NATIONAL SURVEY ASEPP) Dr. José Ramón Doménech. Psychiatrist. Hospital Creu Roja. Barcelona, BIOLOGICAL MARKERS IN PSYCHIATRY. FROM PHARMACOGENETICS TO PHARMACOGENOMICS Dr. José Antonio López Rodríguez. Private practice. Madrid, ETHICS IN PSYCHIATRY. CHALLENGES AND CONFLICTS IN PRIVATE PRACTICE Dr. Blanca Morera. Psychiatrist. Formadora en Bioética Departamento de Política Social de la Diputación de Guipuzcoa, Room 6 09:30 14:00 RETHINKING THE DUAL DIAGNOSIS President: Prof. Pedro Ruiz. Psychiatry and Behavioral Sciences. University of Texas Houston Medical School. Houston, USA. Prof. Miguel Casas. Professor of Psychiatry. Universidad Autónoma de Barcelona. Head of Psychiatry., Hospital Universitari Vall d Hebron, Barcelona, Dr. Nora Volkow. NIDA Director. Prof. John Strang. Professor of Psychiatry of Addictions. Director of the National Addiction Centre. London, UK. Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Prof. Nady el Guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. Dr. Gabriele Fischer Dr. Leo Sher. Associate Clinical Professor of Psychiatry. Medical Center Columbia University. New York, USA. Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. Prof. Alan Green. Dr. José Martínez Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar, Universitat Autònoma Barcelona, Page 46

47 Page 47